<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:32:13Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10122905" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10122905</identifier>
        <datestamp>2023-04-24</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jah38300" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10122905</article-id>
              <article-id pub-id-type="pmcid">PMC10122905</article-id>
              <article-id pub-id-type="pmc-uid">10122905</article-id>
              <article-id pub-id-type="pmid">36974735</article-id>
              <article-id pub-id-type="pmid">36974735</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.122.028821</article-id>
              <article-id pub-id-type="publisher-id">JAH38300</article-id>
              <article-id pub-id-type="other">JAHA/2022/028821-T</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Epidemiology</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Identification of Protein Biomarkers of the Dietary Approaches to Stop Hypertension Diet in Randomized Feeding Studies and Validation in an Observational Study</article-title>
                <alt-title alt-title-type="right-running-head">Protein Biomarkers of the <styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet</alt-title>
                <alt-title alt-title-type="left-running-head">Kim et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah38300-cr-0001" contrib-type="author">
                  <name>
                    <surname>Kim</surname>
                    <given-names>Hyunju</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1707-7018</contrib-id>
                  <xref rid="jah38300-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38300-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0002" contrib-type="author">
                  <name>
                    <surname>Lichtenstein</surname>
                    <given-names>Alice H.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1053-9478</contrib-id>
                  <xref rid="jah38300-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0003" contrib-type="author">
                  <name>
                    <surname>Ganz</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0437-8882</contrib-id>
                  <xref rid="jah38300-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0004" contrib-type="author">
                  <name>
                    <surname>Du</surname>
                    <given-names>Shutong</given-names>
                  </name>
                  <degrees>MHS</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8072-1075</contrib-id>
                  <xref rid="jah38300-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38300-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0005" contrib-type="author">
                  <name>
                    <surname>Tang</surname>
                    <given-names>Olive</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref rid="jah38300-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38300-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0006" contrib-type="author">
                  <name>
                    <surname>Yu</surname>
                    <given-names>Bing</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4818-1077</contrib-id>
                  <xref rid="jah38300-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0007" contrib-type="author">
                  <name>
                    <surname>Chatterjee</surname>
                    <given-names>Nilanjan</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="jah38300-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0008" contrib-type="author">
                  <name>
                    <surname>Appel</surname>
                    <given-names>Lawrence J.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0673-6823</contrib-id>
                  <xref rid="jah38300-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38300-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jah38300-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0009" contrib-type="author">
                  <name>
                    <surname>Coresh</surname>
                    <given-names>Josef</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4598-0669</contrib-id>
                  <xref rid="jah38300-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38300-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jah38300-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jah38300-cr-0010" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Rebholz</surname>
                    <given-names>Casey M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5442-8745</contrib-id>
                  <xref rid="jah38300-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38300-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jah38300-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <address>
                    <email>crebhol1@jhu.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="jah38300-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Epidemiology</named-content>
                <institution>Johns Hopkins Bloomberg School of Public Health</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38300-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Welch Center for Prevention, Epidemiology, and Clinical Research</named-content>
                <institution>Johns Hopkins University</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38300-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Jean Mayer USDA Human Nutrition Research Center on Aging</named-content>
                <institution>Tufts University</institution>
                <city>Boston</city>
                <named-content content-type="country-part">MA</named-content>
              </aff>
              <aff id="jah38300-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Cardiovascular Division, Zuckerberg San Francisco General Hospital</named-content>
                <institution>University of California, San Francisco</institution>
                <city>San Francisco</city>
                <named-content content-type="country-part">CA</named-content>
              </aff>
              <aff id="jah38300-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Epidemiology, Human Genetics &amp; Environmental Sciences</named-content>
                <institution>University of Texas Health Sciences Center at Houston School of Public Health</institution>
                <city>Houston</city>
                <named-content content-type="country-part">TX</named-content>
              </aff>
              <aff id="jah38300-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Department of Biostatistics</named-content>
                <institution>Johns Hopkins Bloomberg School of Public Health</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <aff id="jah38300-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Division of Nephrology, Department of Medicine</named-content>
                <institution>Johns Hopkins School of Medicine</institution>
                <city>Baltimore</city>
                <named-content content-type="country-part">MD</named-content>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>Correspondence to: Casey M. Rebholz, PhD, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 2024 East Monument Street, Suite 2‐500, Baltimore, MD 21287. Email: <email>crebhol1@jhu.edu</email>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>3</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>04</day>
                <month>4</month>
                <year>2023</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="70">7</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.v12.7</issue-id>
              <elocation-id>e028821</elocation-id>
              <history>
                <date date-type="received">
                  <day>20</day>
                  <month>12</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>15</day>
                  <month>2</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <!--Copyright &#x000a9; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell-->
                <copyright-statement content-type="article-copyright">© 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JAH3-12-e028821.pdf"/>
              <abstract>
                <sec id="jah38300-sec-0001">
                  <title>Background</title>
                  <p>The Dietary Approaches to Stop Hypertension (DASH) diet is recommended for cardiovascular disease prevention. We aimed to identify protein biomarkers of the DASH diet using data from 2 randomized feeding studies and validate them in an observational study, the ARIC (Atherosclerosis Risk in Communities) study.</p>
                </sec>
                <sec id="jah38300-sec-0002">
                  <title>Methods and Results</title>
                  <p>Large‐scale proteomic profiling was conducted in serum specimens (SomaLogic) collected at the end of 8‐week and 4‐week DASH diet interventions in multicenter, randomized controlled feeding studies of the DASH trial (N=215) and the DASH‐Sodium trial (N=396), respectively. Multivariable linear regression models were used to compare the relative abundance of 7241 proteins between the DASH and control diet interventions. Estimates from the 2 trials were meta‐analyzed using fixed‐effects models. We validated significant proteins in the ARIC study (N=10 490) using the DASH diet score. At a false discovery rate &lt;0.05, there were 71 proteins that were different between the DASH diet and control diet in the DASH and DASH‐Sodium trials. Nineteen proteins were validated in the ARIC study. The 19 proteins collectively improved the prediction of the DASH diet intervention in the feeding studies (range of difference in C statistics, 0.267–0.313; <italic toggle="no">P</italic>&lt;0.001 for both tests) and the DASH diet score in the ARIC study (difference in C statistics, 0.017; <italic toggle="no">P</italic>&lt;0.001) beyond participant characteristics.</p>
                </sec>
                <sec id="jah38300-sec-0003">
                  <title>Conclusions</title>
                  <p>We identified 19 proteins robustly associated with the DASH diet in 3 studies, which may serve as biomarkers of the DASH diet. These results suggest potential pathways that are impacted by consumption of the DASH diet.</p>
                </sec>
                <sec id="jah38300-sec-0004">
                  <title>Registration</title>
                  <p>URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>; Unique identifiers: NCT03403166, NCT00000608.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah38300-kwd-0001">biomarkers</kwd>
                <kwd id="jah38300-kwd-0002">DASH diet</kwd>
                <kwd id="jah38300-kwd-0003">feeding studies</kwd>
                <kwd id="jah38300-kwd-0004">observational study</kwd>
                <kwd id="jah38300-kwd-0005">protein</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Diet and Nutrition</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Heart, Lung, and Blood Institute
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 HL153178</award-id>
                  <award-id>T32HL007024</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>U.S. Department of Health and Human Services
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000016</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>HHSN268201700005I</award-id>
                  <award-id>HHSN268201700004I</award-id>
                  <award-id>HHSN268201700003I</award-id>
                  <award-id>HHSN268201700002I</award-id>
                  <award-id>HHSN268201700001I</award-id>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute of Diabetes and Digestive and Kidney Diseases
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000062</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R03 DK128386</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="25"/>
                <word-count count="9410"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>04 April 2023</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.7 mode:remove_FC converted:10.04.2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="jah38300-ntgp-0001">
                <fn id="jah38300-note-0001">
                  <p>This article was sent to Kolawole W. Wahab, MD, Guest Editor, for review by expert referees, editorial decision, and final disposition.</p>
                </fn>
                <fn id="jah38300-note-0002">
                  <p>Supplemental Material is available at <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.028821" ext-link-type="uri">https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.028821</ext-link>
</p>
                </fn>
                <fn id="jah38300-note-0003">
                  <p>For Sources of Funding and Disclosures, see page 14.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jah38300-body-0001">
            <def-list list-content="abbreviations" id="jah38300-lp-0001">
              <title>Nonstandard Abbreviations and Acronyms</title>
              <def-item>
                <term id="jah38300-li-0001">AFM</term>
                <def id="jah38300-li-0002">
                  <p>afamin</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0003">ARIC</term>
                <def id="jah38300-li-0004">
                  <p>Atherosclerosis Risk in Communities</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0005">ASAH2</term>
                <def id="jah38300-li-0007">
                  <p>neutral ceramidase</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0008">CCL25</term>
                <def id="jah38300-li-0010">
                  <p>C‐C motif chemokine 25</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0011">CD163</term>
                <def id="jah38300-li-0013">
                  <p>scavenger receptor cysteine‐rich type 1 protein M130</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0014">CTHRC1</term>
                <def id="jah38300-li-0015">
                  <p>collagen triple helix repeat‐containing protein 1</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0016">DASH</term>
                <def id="jah38300-li-0018">
                  <p>Dietary Approaches to Stop Hypertension</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0019">EGFR</term>
                <def id="jah38300-li-0021">
                  <p>epidermal growth factor receptor</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0022">FOLR2</term>
                <def id="jah38300-li-0024">
                  <p>folate receptor β</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0025">GGH</term>
                <def id="jah38300-li-0027">
                  <p>γ‐glutamyl hydrolase</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0028">INHBA</term>
                <def id="jah38300-li-0030">
                  <p>inhibin β A chain</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0031">INHBC</term>
                <def id="jah38300-li-0033">
                  <p>inhibin β C chain</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0034">KREMEN1</term>
                <def id="jah38300-li-0035">
                  <p>kremen protein 1</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0036">LYVE1</term>
                <def id="jah38300-li-0038">
                  <p>lymphatic vessel endothelial hyaluronic acid receptor 1</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0039">MET</term>
                <def id="jah38300-li-0041">
                  <p>hepatocyte growth factor receptor</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0042">PCOLCE</term>
                <def id="jah38300-li-0043">
                  <p>procollagen C‐endopeptidase enhancer 1</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0044">PDRG1</term>
                <def id="jah38300-li-0046">
                  <p>p53 and DNA damage‐regulated protein 1</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0047">PGLYRP2</term>
                <def id="jah38300-li-0048">
                  <p>N‐acetylmuramoyl‐L‐alanine amidase</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0049">RBP4</term>
                <def id="jah38300-li-0051">
                  <p>retinol‐binding protein 4</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0052">S100A14</term>
                <def id="jah38300-li-0053">
                  <p>protein S100‐A14</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38300-li-0054">VAT1</term>
                <def id="jah38300-li-0056">
                  <p>synaptic vesicle membrane protein VAT‐1 homolog</p>
                </def>
              </def-item>
            </def-list>
            <p>
              <boxed-text position="anchor" content-type="box" id="jah38300-blkfxd-0001">
                <caption>
                  <title>Clinical Perspective</title>
                </caption>
                <sec id="jah38300-sec-0008">
                  <title>What Is New?</title>
                  <p>
                    <list list-type="bullet" id="jah38300-list-0001">
                      <list-item id="jah38300-li-0057">
                        <p>The Dietary Approaches to Stop Hypertension (DASH) diet is recommended by the <italic toggle="yes">Dietary Guidelines for Americans</italic> for the prevention of cardiovascular disease.</p>
                      </list-item>
                      <list-item id="jah38300-li-0058">
                        <p>We identified circulating protein biomarkers of the DASH diet in 2 randomized feeding studies and validated them in an observational study.</p>
                      </list-item>
                      <list-item id="jah38300-li-0059">
                        <p>Nineteen circulating proteins were robustly associated with the DASH diet, which reflected dietary intake, lower inflammation, and collagen deposition.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
                <sec id="jah38300-sec-0009">
                  <title>What Are the Clinical Implications?</title>
                  <p>
                    <list list-type="bullet" id="jah38300-list-0002">
                      <list-item id="jah38300-li-0060">
                        <p>These proteins may serve as objective biomarkers of the DASH diet, addressing important gaps related to self‐reported diet in nutritional epidemiologic research.</p>
                      </list-item>
                      <list-item id="jah38300-li-0061">
                        <p>The 19 proteins associated with the DASH diet can help further our understanding on the mechanisms through which the DASH diet is associated with cardiometabolic diseases.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </boxed-text>
            </p>
            <p>The Dietary Approaches to Stop Hypertension (DASH) diet is recommended by the <italic toggle="yes">Dietary Guidelines for Americans</italic> for the prevention of cardiovascular disease.<xref rid="jah38300-bib-0001" ref-type="bibr"><sup>1</sup></xref> The DASH diet is high in fruits, vegetables, and low‐fat dairy foods; moderate in fish, poultry, nuts, and seeds; and low in sugar‐sweetened beverages, sweets, and red and processed meats.<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref> In the original DASH trial, a randomized controlled feeding study, the DASH diet significantly lowered blood pressure in adults with pre‐ or stage 1 hypertension.<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref> Subsequently, in the DASH‐Sodium trial, the DASH diet combined with low dietary intake of sodium significantly lowered blood pressure compared with the DASH diet higher in sodium or the control diet.<xref rid="jah38300-bib-0003" ref-type="bibr"><sup>3</sup></xref> Since then, many observational studies have identified associations of the DASH diet with a lower risk of hypertension, diabetes, kidney and cardiovascular diseases, and other diseases.<xref rid="jah38300-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="jah38300-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jah38300-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38300-bib-0007" ref-type="bibr"><sup>7</sup></xref>
</p>
            <p>Assessment of adherence to the DASH diet within free‐living populations relies on self‐reported data. However, self‐reported data are prone to measurement error and systematic biases such as recall and socially desirable biases.<xref rid="jah38300-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="jah38300-bib-0009" ref-type="bibr"><sup>9</sup></xref> Objective biomarkers of the DASH diet that are not influenced by these factors can complement or replace existing approaches to dietary assessment.<xref rid="jah38300-bib-0010" ref-type="bibr"><sup>10</sup></xref>
</p>
            <p>Proteomics, a method that screens thousands of proteins in a single biospecimen, may be used to identify functional biomarkers of dietary intake.<xref rid="jah38300-bib-0011" ref-type="bibr"><sup>11</sup></xref> These proteins may offer insights on the underlying mechanism(s) through which diet is associated with cardiometabolic outcomes, given that proteins are integral to many biological processes.<xref rid="jah38300-bib-0011" ref-type="bibr"><sup>11</sup></xref>, <xref rid="jah38300-bib-0012" ref-type="bibr"><sup>12</sup></xref>, <xref rid="jah38300-bib-0013" ref-type="bibr"><sup>13</sup></xref>
</p>
            <p>Few prior studies identified protein biomarkers of dietary patterns. These studies used empirically derived dietary patterns or established diet indices such as the DASH diet score, Alternative Health Eating Index, and Mediterranean‐style diet.<xref rid="jah38300-bib-0014" ref-type="bibr"><sup>14</sup></xref>, <xref rid="jah38300-bib-0015" ref-type="bibr"><sup>15</sup></xref> These studies were highly promising in identifying novel biomarkers but were limited by a lack of validation and use of self‐reported diet. To minimize spurious associations, it is important to validate biomarkers in independent study populations and across study designs.<xref rid="jah38300-bib-0016" ref-type="bibr"><sup>16</sup></xref>
</p>
            <p>Therefore, the present study aimed to (1) identify protein biomarkers of the DASH diet using data from 2 randomized controlled feeding studies and (2) validate these proteins using data from a large observational cohort study.</p>
            <sec sec-type="methods" id="jah38300-sec-0010">
              <title>Methods</title>
              <sec id="jah38300-sec-0011">
                <title>Study Design and Population</title>
                <p>Study data of the DASH trial, DASH‐Sodium trial, and the ARIC (Atherosclerosis Risk in Communities) study are available through the National Heart, Lung, and Blood Institute Biologic Specimen and Data Repository Information Coordinating Center. Interested researchers may also contact the ARIC study coordinating center to access data. The DASH and the DASH‐Sodium trials were multicenter, randomized controlled feeding studies that aimed to test the effect of the DASH diet on blood pressure. Details on the design of these studies have been published.<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="jah38300-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="jah38300-bib-0017" ref-type="bibr"><sup>17</sup></xref> In the DASH trial, after a 3‐week run‐in period, participants were randomly assigned to the DASH diet, fruit and vegetables diet, or the control diet, which lasted 8 weeks (Figure <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S1</xref>).<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref> Individuals who were included in the DASH trial were adults (≥22 years of age) with systolic blood pressure &lt;160 mm Hg and diastolic blood pressure 80 to 95 mm Hg.</p>
                <p>The DASH‐Sodium trial was designed to examine the combined effect of the DASH diet and sodium (low, medium, and high) on blood pressure. In the DASH‐Sodium trial, after a 2‐week run‐in period, participants were randomly assigned to either the DASH diet or control diet for 12 weeks (parallel arm design).<xref rid="jah38300-bib-0003" ref-type="bibr"><sup>3</sup></xref> Within each diet, participants consumed low, medium, and high levels of sodium in random order for 4 weeks each (crossover design), and each sodium period was separated by up to 5 days.<xref rid="jah38300-bib-0018" ref-type="bibr"><sup>18</sup></xref> Carryover from one sodium period to the next was expected to be minimal.<xref rid="jah38300-bib-0018" ref-type="bibr"><sup>18</sup></xref> Eligibility criteria for the DASH and DASH‐Sodium trials were similar. Procedures were followed in accordance with the ethical standards of the institutional review boards at all study centers, and written informed consent was obtained from participants. The DASH and DASH‐Sodium trials were registered at <ext-link xlink:href="http://clinicaltrials.gov/" ext-link-type="uri">http://clinicaltrials.gov/</ext-link> as NCT03403166 and NCT00000608, respectively. The first author had full access to all of the data in the study and takes responsibility for its integrity and the data analysis.</p>
                <p>For the present proteomics study, stored serum specimens were obtained from the National Heart, Lung, and Blood Institute Biologic Specimen and Data Repository Coordinating Center.<xref rid="jah38300-bib-0019" ref-type="bibr"><sup>19</sup></xref> To characterize the proteome of the DASH diet, we compared serum specimens collected at the end of the (1) DASH diet and control diet interventions in the DASH trial and (2) DASH high‐sodium and control high‐sodium phases in the DASH‐Sodium trial. We selected the same high‐sodium phases in the DASH‐Sodium trial to provide a similar comparison of diet interventions as the DASH trial. For the present study, we used the same exclusion criteria for the DASH and DASH‐Sodium trials. Of the participants who participated in the DASH diet or control diet interventions (ie, excluding those randomized to the fruits and vegetables arm in the DASH trial; n<sub>DASH</sub>=305; n<sub>DASH‐Sodium</sub>=412), we excluded participants who did not consent to use of their stored biospecimens or had no available stored serum specimens (n<sub>DASH</sub>=88; n<sub>DASH‐Sodium</sub>=16) and participants with a flagged specimen by the laboratory (SomaLogic, Boulder, CO) suspected of poor sample quality (n<sub>DASH</sub>=2; n<sub>DASH‐Sodium</sub>=0) (Figure <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S2</xref>). After these exclusions, the analytic sample was 215 participants for the DASH trial and 396 participants for the DASH‐Sodium trial.</p>
              </sec>
              <sec id="jah38300-sec-0012">
                <title><styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet</title>
                <p>The DASH diet emphasizes greater intake of fruits, vegetables, and low‐fat dairy foods; is low in red and processed meats, sugar‐sweetened beverages, and sweets; and includes different sources of proteins such as fish, poultry, nuts, and beans.<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="jah38300-bib-0017" ref-type="bibr"><sup>17</sup></xref> The DASH and DASH‐Sodium trials used a 7‐day menu cycle (21 meals). The nutrient composition of the diet interventions in both trials have been published previously.<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="jah38300-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="jah38300-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jah38300-bib-0018" ref-type="bibr"><sup>18</sup></xref> Compared with the typical American diet (control diet), the DASH diet was designed to be higher in protein and fiber and lower in cholesterol and fat, especially saturated fat. Potassium, magnesium, and calcium intake was at the 75th percentile of consumption in the United States in the 1970s to 1980s. The control diet mirrored a typical American diet in that the macronutrient profile and fiber intake was close to average US consumption, whereas potassium, magnesium, and calcium intakes were at the 25th percentile of US consumption. The sodium content of the DASH diet and the control diet was similar (≈3000 mg) in the DASH trial. Sodium content was divided into 3 levels in the DASH‐Sodium trial. In the present proteomics study, we profiled samples from the high‐sodium phases (≈3600 mg/d of sodium) in the DASH‐Sodium trial to be as similar as possible to the sodium intake in the DASH trial and to be similar to average sodium intake in the United States. Considering the similarity in sodium content between the 2 feeding studies and between DASH and control interventions in both studies, it was expected that protein biomarkers identified would represent aspects of the DASH diet unrelated to sodium.</p>
                <p>During the intervention periods, participants' body weight was measured each weekday, and total energy intake was adjusted to keep body weight stable. All meals were prepared in research kitchens using standardized menus. During weekdays, participants ate either lunch or dinner at study sites. Participants received cooked meals and snacks to be consumed on the weekends and offsite.</p>
              </sec>
              <sec id="jah38300-sec-0013">
                <title>Protein Measurements in the <styled-content style="fixed-case" toggle="no">DASH</styled-content> and <styled-content style="fixed-case" toggle="no">DASH‐Sodium</styled-content> Trials</title>
                <p>From the DASH and DASH‐Sodium trials, fasting (&gt;8 hours) serum specimens, which were stored at −70 °C, were sent to SomaLogic. A slow off‐rate modified aptamer–based capture array named SOMAScan version 4.1 was used to identify &gt;7000 protein targets and protein complexes. Details on the SOMAScan methods have been published previously.<xref rid="jah38300-bib-0020" ref-type="bibr"><sup>20</sup></xref>, <xref rid="jah38300-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="jah38300-bib-0022" ref-type="bibr"><sup>22</sup></xref> Briefly, the SOMAScan assay uses slow off‐rate modified aptamers, chemically modified, short single‐stranded DNA molecules as binding reagents to identify proteins and protein complexes. The SOMAScan platform has high sensitivity, similar to that of immunoassays.<xref rid="jah38300-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="jah38300-bib-0022" ref-type="bibr"><sup>22</sup></xref> Each serum specimen is mixed with thousands of slow off‐rate modified aptamers, then undergoes a capture, washing, and recapture process to identify cognate slow off‐rate modified aptamer and protein complexes with high specificity. Proteins that were captured during these steps can be quantified using standard DNA microarrays in relative fluorescence units. Then, relative abundance of all proteins was standardized and normalized to remove variations within an assay run and between runs. The SOMAScan assay had low intra‐ and interrun coefficient variation (5%) and high intraclass correlation coefficients (0.9).<xref rid="jah38300-bib-0023" ref-type="bibr"><sup>23</sup></xref>, <xref rid="jah38300-bib-0024" ref-type="bibr"><sup>24</sup></xref> Details on quality control in the DASH and DASH‐Sodium trials are found in Data <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S1</xref>.</p>
                <p>The SOMAScan assay identified 7596 proteins in the DASH and DASH‐Sodium trials. In both trials, we excluded proteins that bound to Fc‐fusion mouse (n=233), bound to a contaminant (n=0), nonproteins that were hybridization control elution or nonhuman proteins (n=73), and proteins that were missing UniProt ID (n=0). Then, of the 7290 remaining proteins in both trials, we excluded proteins with coefficient of variation &gt;50% (n<sub>DASH</sub>=32, n<sub>DASH‐Sodium</sub>=20) and proteins with low variance (&lt;0.01 on the log<sub>2</sub> scale) (n<sub>DASH</sub>=0, n<sub>DASH‐Sodium</sub>=14). After these quality control steps, in the DASH and DASH‐Sodium trials, 7258 proteins and 7256 proteins remained, respectively. Of these, we focused on 7241 proteins that were in common between the DASH and DASH‐Sodium trials.</p>
              </sec>
              <sec id="jah38300-sec-0014">
                <title>Validation: The <styled-content style="fixed-case" toggle="no">ARIC</styled-content> Study</title>
                <p>The ARIC study is a community‐based prospective study of predominantly Black and White men and women in the United States.<xref rid="jah38300-bib-0025" ref-type="bibr"><sup>25</sup></xref> In 1987 to 1989 (Visit 1), the ARIC study enrolled 15 792 adults between 45 and 64 years of age from 4 communities (Minneapolis, MN; Jackson, MS; Forsyth County, NC; and Washington County, MD).</p>
                <p>Dietary assessment and protein measurement was conducted at Visit 3 (1993–1995). Trained interviewers collected data on usual intake of foods and beverages, using a 66‐item semiquantitative food frequency questionnaire. Participants reported the frequency with which they consumed foods and beverages of a certain serving size in the past year. Visual aids helped participants estimate the serving size. The responses on the food frequency questionnaire were used to calculate the DASH diet score. Detailed description and calculation of the DASH diet score in the ARIC study has been published.<xref rid="jah38300-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38300-bib-0026" ref-type="bibr"><sup>26</sup></xref> Briefly, the DASH diet score had 8 components. Higher intake of 5 components (fruits, vegetables, whole grains, nuts and legumes, and low‐fat dairy) received higher scores. Higher intake of 3 components (red and processed meats, sugar‐sweetened beverages, and sodium) received lower scores. For each component, participants were ranked based on their reported intake and could receive a score between 1 and 5 points. The theoretical range of the DASH diet score was 8 to 40, with a higher score representing greater adherence to the DASH diet.</p>
                <p>In the ARIC study, large‐scale protein profiling using fasting plasma specimens was conducted by SomaLogic, the same biotechnology company that measured proteins in the DASH and DASH‐Sodium trials, and identified 5284 proteins and protein targets. Detailed methods and quality control of the proteomic data in the ARIC study have been published and are available in Data <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S1</xref>.<xref rid="jah38300-bib-0027" ref-type="bibr"><sup>27</sup></xref>, <xref rid="jah38300-bib-0028" ref-type="bibr"><sup>28</sup></xref>
</p>
                <p>Of the 11 478 participants who attended Visit 3 and had complete proteomics data, we excluded participants based on the following criteria: (1) missing &gt;10 items on the food frequency questionnaire (n=107), (2) those with implausible total energy intake (women &lt;500 or &gt;3500 kcal/d and men &lt;600 or &gt;4500 kcal/d, n=269), (3) those who were neither White nor Black (ie, Asian or American Indian), and Black individuals from 2 sites (Minneapolis, MN and Washington County, MD) because of the small sample size (n=67), (4) those with missing covariates (n=429), and (5) those with incomplete responses on dietary data that precluded calculating the DASH diet score (n=116). The analytic sample for the validation study was 10 490 participants.</p>
              </sec>
              <sec id="jah38300-sec-0015">
                <title>Statistical Analysis</title>
                <p>Baseline characteristics of the study population in the DASH and DASH‐Sodium trials were examined using means and SDs for continuous variables and proportions for categorical variables. Characteristics of the study population were also examined by diet interventions (DASH versus control diets) within each trial.</p>
                <p>To examine the association between the DASH diet and 7241 serum proteins in the DASH and DASH‐Sodium trials, we conducted multivariable linear regression models using randomized diet interventions as the independent variable and proteins as the response variable. In each study, we adjusted for age, sex, race and ethnicity, and body mass index. Although participants were randomly assigned to diet interventions, we adjusted for baseline covariates, because the present proteomics study used data from a subset of participants and to improve precision. Then, estimates from multivariable linear regression models were meta‐analyzed using fixed‐effects models across the 2 trials, using the metafor package and inverse variance weights for calculation of standard errors. We selected a fixed‐effects model, given the similarities of the study design, conduct of the study, study setting, study populations, procedures, and dietary interventions between the DASH and DASH‐Sodium trials. Additionally, the Cochran <italic toggle="yes">Q</italic> test was not statistically significant for 6952 (96%) of the total of 7241 proteins (<italic toggle="yes">P</italic>&gt;0.05). Proteins were considered statistically significant at a false discovery rate (FDR) &lt;0.05.<xref rid="jah38300-bib-0029" ref-type="bibr"><sup>29</sup></xref>
</p>
                <p>Then, we conducted validation analyses in the ARIC study. Only the proteins that were significantly different between the DASH and control diets from the DASH and DASH‐Sodium trials were considered for validation analyses. In the ARIC study, multivariable linear regression models were used to assess the association between 1 SD higher in the DASH diet score (independent variable) and log<sub>2</sub>‐transformed proteins (response variable), adjusting for sociodemographic characteristics (age, sex, race, study center, education), total energy intake, health behaviors (alcohol intake, smoking, physical activity), and clinical factors (estimated glomerular filtration rate, diabetes, and body mass index). We adjusted for more covariates than the DASH and DASH‐Sodium trials, given that the ARIC study is an observational study. Of the 71 proteins that were associated with the DASH diet in the 2 trials, 50 proteins were available in the ARIC study. We considered proteins to be validated if proteins were statistically significantly associated with the DASH diet score at an FDR threshold &lt;0.05 to account for multiple comparisons and had a consistent direction of association with the DASH and DASH‐Sodium trials.</p>
                <p>Next, we calculated C statistics to assess whether the validated proteins individually and collectively predicted the DASH diet intervention in the DASH trial and the DASH‐Sodium trial beyond age, sex, race and ethnicity, and body mass index (covariates used in regression models). Similarly, in the ARIC study, we examined whether the validated proteins predicted those in the highest quartile compared with 3 lower quartiles of the DASH diet score beyond the participant characteristics (covariates in the regression models in the ARIC study). The highest quartile of the DASH diet indicates the highest adherence to the DASH diet. Greater adherence to the DASH diet was associated with a lower risk of important chronic diseases.<xref rid="jah38300-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="jah38300-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="jah38300-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38300-bib-0007" ref-type="bibr"><sup>7</sup></xref> Lastly, we conducted sex‐stratified analyses of the validated proteins in the DASH and DASH‐Sodium trials and tested for interaction by sex. Estimates from sex‐stratified analyses were meta‐analyzed using a fixed‐effects model across the 2 trials. All analyses were conducted using R software version 4.1.0 (R Foundation for Statistical Computing).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jah38300-sec-0016">
              <title>Results</title>
              <sec id="jah38300-sec-0017">
                <title>Participant Characteristics</title>
                <p>Baseline characteristics were generally similar in the DASH and DASH‐Sodium trials (Table <xref rid="jah38300-tbl-0001" ref-type="table">1</xref>). In both trials, more than half of the participants were between the ages of 31 and 50 years and identified as belonging to a racial minority group. In both trials, approximately half of the participants were women. Those in the DASH trial were more likely to be in the middle‐income category ($30 000–$59 999). Other characteristics, such as education, smoking, and body mass index were similar across the DASH and the DASH‐Sodium trials. In the DASH‐Sodium trial, systolic blood pressure and diastolic blood pressure levels were slightly higher, which led to a greater proportion of participants classified as having hypertension (40.7% in the DASH‐Sodium trial compared with 26.0% in the DASH trial). These characteristics were similarly distributed when participants were stratified by the randomized diet interventions (Table <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S1</xref>).</p>
                <table-wrap position="float" id="jah38300-tbl-0001" content-type="Table">
                  <label>Table 1</label>
                  <caption>
                    <p>Characteristics of the Participants in the DASH and DASH‐Sodium Trials<xref rid="jah38300-note-0005" ref-type="table-fn">*</xref>
</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Characteristic</th>
                        <th align="left" rowspan="1" colspan="1">
                          <p>DASH,</p>
                          <p>N=215</p>
                        </th>
                        <th align="left" rowspan="1" colspan="1">
                          <p>DASH‐Sodium,</p>
                          <p>N=396</p>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">Age, y, n (%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">≤30</td>
                        <td align="left" rowspan="1" colspan="1">26 (12.1%)</td>
                        <td align="left" rowspan="1" colspan="1">12 (3.0%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">31–50</td>
                        <td align="left" rowspan="1" colspan="1">119 (55.3%)</td>
                        <td align="left" rowspan="1" colspan="1">233 (58.8%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">≥51</td>
                        <td align="left" rowspan="1" colspan="1">70 (32.6%)</td>
                        <td align="left" rowspan="1" colspan="1">151 (38.1%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Women, n (%)</td>
                        <td align="left" rowspan="1" colspan="1">102 (47.4%)</td>
                        <td align="left" rowspan="1" colspan="1">225 (56.8%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Minority race, n (%)<xref rid="jah38300-note-0006" ref-type="table-fn">†</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">123 (57.2%)</td>
                        <td align="left" rowspan="1" colspan="1">227 (57.3%)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">Income, n (%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">&lt;$29 999</td>
                        <td align="left" rowspan="1" colspan="1">71 (33.0%)</td>
                        <td align="left" rowspan="1" colspan="1">126 (31.8%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">$30 000–$59 999</td>
                        <td align="left" rowspan="1" colspan="1">95 (44.2%)</td>
                        <td align="left" rowspan="1" colspan="1">144 (36.4%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">≥$60 000</td>
                        <td align="left" rowspan="1" colspan="1">47 (21.9%)</td>
                        <td align="left" rowspan="1" colspan="1">117 (29.5%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Not answered</td>
                        <td align="left" rowspan="1" colspan="1">2 (0.9%)</td>
                        <td align="left" rowspan="1" colspan="1">9 (2.3%)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">Education, n (%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">High school graduate or less</td>
                        <td align="left" rowspan="1" colspan="1">33 (15.3%)</td>
                        <td align="left" rowspan="1" colspan="1">65 (16.4%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">College graduate</td>
                        <td align="left" rowspan="1" colspan="1">59 (27.4%)</td>
                        <td align="left" rowspan="1" colspan="1">94 (23.7%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Postgraduate work/degree</td>
                        <td align="left" rowspan="1" colspan="1">79 (36.7%)</td>
                        <td align="left" rowspan="1" colspan="1">145 (36.6%)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Some college</td>
                        <td align="left" rowspan="1" colspan="1">44 (20.5%)</td>
                        <td align="left" rowspan="1" colspan="1">91 (23.0%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Current smoker, n (%)</td>
                        <td align="left" rowspan="1" colspan="1">18 (8.4%)</td>
                        <td align="left" rowspan="1" colspan="1">42 (10.6%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Weight, kg</td>
                        <td align="left" rowspan="1" colspan="1">82.7 (14.8)</td>
                        <td align="left" rowspan="1" colspan="1">84.0 (15.2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Height, cm</td>
                        <td align="left" rowspan="1" colspan="1">170.9 (9.1)</td>
                        <td align="left" rowspan="1" colspan="1">169.7 (9.2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI, kg/m<sup>2</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">28.2 (3.9)</td>
                        <td align="left" rowspan="1" colspan="1">29.2 (4.7)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">SBP, mm Hg</td>
                        <td align="left" rowspan="1" colspan="1">130.8 (10.5)</td>
                        <td align="left" rowspan="1" colspan="1">134.8 (9.5)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">DBP, mm Hg</td>
                        <td align="left" rowspan="1" colspan="1">84.6 (4.4)</td>
                        <td align="left" rowspan="1" colspan="1">85.7 (4.5)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Hypertensive status, n (%)<xref rid="jah38300-note-0007" ref-type="table-fn">‡</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">56 (26.0%)</td>
                        <td align="left" rowspan="1" colspan="1">161 (40.7%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Ever used BP medication, n (%)</td>
                        <td align="left" rowspan="1" colspan="1">46 (21.4%)</td>
                        <td align="left" rowspan="1" colspan="1">70 (17.7%)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38300-ntgp-0002">
                    <fn id="jah38300-note-0004">
                      <p>BMI indicates body mass index; BP, blood pressure; DASH, Dietary Approaches to Stop Hypertension; DBP, diastolic blood pressure; and SBP, systolic blood pressure.</p>
                    </fn>
                    <fn id="jah38300-note-0005">
                      <label>*</label>
                      <p>Values are n (%) for categorical variables and mean (SD) for continuous variables.</p>
                    </fn>
                    <fn id="jah38300-note-0006">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>The trials collected information on race (minority race vs nonminority race). Minority race refers to Black individuals.</p>
                    </fn>
                    <fn id="jah38300-note-0007">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p>Hypertensive status was defined as SBP ≥140 mm Hg or DBP ≥90 mm Hg.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="jah38300-sec-0018">
                <title>Individual Proteins Differed Significantly Between the <styled-content style="fixed-case" toggle="no">DASH</styled-content> and Control Diets in the <styled-content style="fixed-case" toggle="no">DASH</styled-content> and <styled-content style="fixed-case" toggle="no">DASH‐Sodium</styled-content> Trials</title>
                <p>Out of 7241 proteins detected, relative abundance of 71 proteins was significantly different between the DASH and control diets in the DASH and DASH‐Sodium trials at FDR &lt;0.05 after meta‐analysis (Table <xref rid="jah38300-tbl-0002" ref-type="table">2</xref>; Figure <xref rid="jah38300-fig-0001" ref-type="fig">1</xref>). Abundance of 41 proteins was higher, whereas abundance of 30 proteins was lower for participants consuming the DASH diet compared with the control diet. Proteins that were positively associated with the DASH diet included RBP4 (retinol‐binding protein 4), FOLR2 (folate receptor β), and EGFR (epidermal growth factor receptor). These proteins were not statistically different between diet interventions in the DASH trial, but were significantly different between diet interventions after meta‐analysis. Proteins that were negatively associated with the DASH diet included AFM (afamin), PGLYRP2 (N‐acetylmuramoyl‐L‐alanine amidase), GGH (γ‐glutamyl hydrolase), and INHBA (inhibin β A chain). Of these, GGH was the only protein that was not statistically different between the DASH and control diets in the DASH trial. Three proteins (CD209 antigen, AFM, and activin A) had duplicate protein targets (2 duplicates for CD209 antigen, and 1 duplicate for AFM and activin A). These duplicates were associated with the DASH diet in the same direction, but 1 duplicate protein target for CD209 antigen did not meet FDR &lt;0.05 criterion after meta‐analysis.</p>
                <table-wrap position="float" id="jah38300-tbl-0002" content-type="Table">
                  <label>Table 2</label>
                  <caption>
                    <p>Seventy‐One Proteins Significantly Different Between the DASH Diet Compared With the Control Diet in the DASH and DASH‐Sodium Trials<xref rid="jah38300-note-0009" ref-type="table-fn">*</xref>
</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Uniprot ID</th>
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Entrezgene symbol</th>
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Protein name</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">DASH trial</th>
                        <th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1">DASH‐Sodium trial</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">Meta‐analysis</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">β</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th>
                        <th align="left" rowspan="1" colspan="1">β</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic>‐value</th>
                        <th align="left" rowspan="1" colspan="1">β</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th>
                        <th align="left" rowspan="1" colspan="1">FDR‐adjusted <italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NTN9</td>
                        <td align="left" rowspan="1" colspan="1">SEMA4G</td>
                        <td align="left" rowspan="1" colspan="1">Semaphorin‐4G</td>
                        <td align="left" rowspan="1" colspan="1">0.1317</td>
                        <td align="left" rowspan="1" colspan="1">2.07 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1399</td>
                        <td align="left" rowspan="1" colspan="1">5.93 E‐07</td>
                        <td align="left" rowspan="1" colspan="1">0.1374</td>
                        <td align="left" rowspan="1" colspan="1">2.57 E‐09</td>
                        <td align="left" rowspan="1" colspan="1">1.86 E‐05</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NNX6</td>
                        <td align="left" rowspan="1" colspan="1">CD209</td>
                        <td align="left" rowspan="1" colspan="1">CD209 antigen</td>
                        <td align="left" rowspan="1" colspan="1">−0.2122</td>
                        <td align="left" rowspan="1" colspan="1">4.66 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.1667</td>
                        <td align="left" rowspan="1" colspan="1">1.38 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.1858</td>
                        <td align="left" rowspan="1" colspan="1">1.84 E‐08</td>
                        <td align="left" rowspan="1" colspan="1">6.66 E‐05</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P09110</td>
                        <td align="left" rowspan="1" colspan="1">ACAA1</td>
                        <td align="left" rowspan="1" colspan="1">3‐ketoacyl‐CoA thiolase, peroxisomal</td>
                        <td align="left" rowspan="1" colspan="1">0.3399</td>
                        <td align="left" rowspan="1" colspan="1">1.62 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.2901</td>
                        <td align="left" rowspan="1" colspan="1">7.94 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">0.3034</td>
                        <td align="left" rowspan="1" colspan="1">3.27 E‐08</td>
                        <td align="left" rowspan="1" colspan="1">6.69 E‐05</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96IY4</td>
                        <td align="left" rowspan="1" colspan="1">CPB2</td>
                        <td align="left" rowspan="1" colspan="1">Carboxypeptidase B2</td>
                        <td align="left" rowspan="1" colspan="1">0.1030</td>
                        <td align="left" rowspan="1" colspan="1">7.84 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.0703</td>
                        <td align="left" rowspan="1" colspan="1">1.16 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0812</td>
                        <td align="left" rowspan="1" colspan="1">3.70 E‐08</td>
                        <td align="left" rowspan="1" colspan="1">6.69 E‐05</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O95445</td>
                        <td align="left" rowspan="1" colspan="1">APOM</td>
                        <td align="left" rowspan="1" colspan="1">Apolipoprotein M</td>
                        <td align="left" rowspan="1" colspan="1">−0.1489</td>
                        <td align="left" rowspan="1" colspan="1">3.26 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.0819</td>
                        <td align="left" rowspan="1" colspan="1">1.66 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1055</td>
                        <td align="left" rowspan="1" colspan="1">3.96 E‐07</td>
                        <td align="left" rowspan="1" colspan="1">5.74 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P08476</td>
                        <td align="left" rowspan="1" colspan="1">INHBA</td>
                        <td align="left" rowspan="1" colspan="1">Activin A</td>
                        <td align="left" rowspan="1" colspan="1">−0.1708</td>
                        <td align="left" rowspan="1" colspan="1">1.98 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.1888</td>
                        <td align="left" rowspan="1" colspan="1">1.35 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.1842</td>
                        <td align="left" rowspan="1" colspan="1">6.03 E‐07</td>
                        <td align="left" rowspan="1" colspan="1">6.98 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96KN2</td>
                        <td align="left" rowspan="1" colspan="1">CNDP1</td>
                        <td align="left" rowspan="1" colspan="1">β‐Ala‐His dipeptidase</td>
                        <td align="left" rowspan="1" colspan="1">0.2006</td>
                        <td align="left" rowspan="1" colspan="1">1.56 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1857</td>
                        <td align="left" rowspan="1" colspan="1">1.68 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1913</td>
                        <td align="left" rowspan="1" colspan="1">6.75 E‐07</td>
                        <td align="left" rowspan="1" colspan="1">6.98 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NNX6</td>
                        <td align="left" rowspan="1" colspan="1">CD209</td>
                        <td align="left" rowspan="1" colspan="1">CD209 antigen</td>
                        <td align="left" rowspan="1" colspan="1">−0.1624</td>
                        <td align="left" rowspan="1" colspan="1">4.94 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1585</td>
                        <td align="left" rowspan="1" colspan="1">6.50 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.1598</td>
                        <td align="left" rowspan="1" colspan="1">7.94 E‐07</td>
                        <td align="left" rowspan="1" colspan="1">7.09 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q15113</td>
                        <td align="left" rowspan="1" colspan="1">PCOLCE</td>
                        <td align="left" rowspan="1" colspan="1">Procollagen C‐endopeptidase enhancer 1</td>
                        <td align="left" rowspan="1" colspan="1">0.0846</td>
                        <td align="left" rowspan="1" colspan="1">2.33 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1258</td>
                        <td align="left" rowspan="1" colspan="1">1.16 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.1106</td>
                        <td align="left" rowspan="1" colspan="1">8.81 E‐07</td>
                        <td align="left" rowspan="1" colspan="1">7.09 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O94819</td>
                        <td align="left" rowspan="1" colspan="1">KBTBD11</td>
                        <td align="left" rowspan="1" colspan="1">Kelch repeat and BTB domain‐containing protein 11</td>
                        <td align="left" rowspan="1" colspan="1">0.0818</td>
                        <td align="left" rowspan="1" colspan="1">1.43 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0850</td>
                        <td align="left" rowspan="1" colspan="1">3.39 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.0842</td>
                        <td align="left" rowspan="1" colspan="1">1.13 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">8.19 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P08476</td>
                        <td align="left" rowspan="1" colspan="1">INHBA</td>
                        <td align="left" rowspan="1" colspan="1">Inhibin β A chain</td>
                        <td align="left" rowspan="1" colspan="1">−0.1948</td>
                        <td align="left" rowspan="1" colspan="1">3.60 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.1155</td>
                        <td align="left" rowspan="1" colspan="1">6.48 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.1378</td>
                        <td align="left" rowspan="1" colspan="1">1.31 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">8.61 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9BZR6</td>
                        <td align="left" rowspan="1" colspan="1">RTN4R</td>
                        <td align="left" rowspan="1" colspan="1">Reticulon‐4 receptor</td>
                        <td align="left" rowspan="1" colspan="1">0.0854</td>
                        <td align="left" rowspan="1" colspan="1">3.28 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1196</td>
                        <td align="left" rowspan="1" colspan="1">1.74 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.1086</td>
                        <td align="left" rowspan="1" colspan="1">1.59 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">9.57 E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96PD5</td>
                        <td align="left" rowspan="1" colspan="1">PGLYRP2</td>
                        <td align="left" rowspan="1" colspan="1">N‐acetylmuramoyl‐L‐alanine amidase</td>
                        <td align="left" rowspan="1" colspan="1">−0.1030</td>
                        <td align="left" rowspan="1" colspan="1">9.89 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0827</td>
                        <td align="left" rowspan="1" colspan="1">6.97 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0905</td>
                        <td align="left" rowspan="1" colspan="1">2.02 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.09 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q86VB7</td>
                        <td align="left" rowspan="1" colspan="1">CD163</td>
                        <td align="left" rowspan="1" colspan="1">Scavenger receptor cysteine‐rich type 1 protein M130</td>
                        <td align="left" rowspan="1" colspan="1">0.1705</td>
                        <td align="left" rowspan="1" colspan="1">7.84 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1673</td>
                        <td align="left" rowspan="1" colspan="1">1.09 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1683</td>
                        <td align="left" rowspan="1" colspan="1">2.12 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.09 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9UPZ6</td>
                        <td align="left" rowspan="1" colspan="1">THSD7A</td>
                        <td align="left" rowspan="1" colspan="1">Thrombospondin type‐1 domain‐containing protein 7A: thrombospondin type‐1 domain 6</td>
                        <td align="left" rowspan="1" colspan="1">0.2159</td>
                        <td align="left" rowspan="1" colspan="1">2.39 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1881</td>
                        <td align="left" rowspan="1" colspan="1">3.66 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1980</td>
                        <td align="left" rowspan="1" colspan="1">2.36 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.14 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9Y624</td>
                        <td align="left" rowspan="1" colspan="1">F11R</td>
                        <td align="left" rowspan="1" colspan="1">Junctional adhesion molecule A</td>
                        <td align="left" rowspan="1" colspan="1">0.0306</td>
                        <td align="left" rowspan="1" colspan="1">6.12 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1165</td>
                        <td align="left" rowspan="1" colspan="1">2.79 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">0.1043</td>
                        <td align="left" rowspan="1" colspan="1">4.29 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.89 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9HCY8</td>
                        <td align="left" rowspan="1" colspan="1">S100A14</td>
                        <td align="left" rowspan="1" colspan="1">Protein S100‐A14</td>
                        <td align="left" rowspan="1" colspan="1">0.0638</td>
                        <td align="left" rowspan="1" colspan="1">5.04 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0891</td>
                        <td align="left" rowspan="1" colspan="1">3.34 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.0815</td>
                        <td align="left" rowspan="1" colspan="1">4.43 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.89 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P04003</td>
                        <td align="left" rowspan="1" colspan="1">C4BPA</td>
                        <td align="left" rowspan="1" colspan="1">C4b‐binding protein α chain</td>
                        <td align="left" rowspan="1" colspan="1">0.1143</td>
                        <td align="left" rowspan="1" colspan="1">2.39 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0688</td>
                        <td align="left" rowspan="1" colspan="1">4.23 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0860</td>
                        <td align="left" rowspan="1" colspan="1">4.88 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.92 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NUG6</td>
                        <td align="left" rowspan="1" colspan="1">PDRG1</td>
                        <td align="left" rowspan="1" colspan="1">p53 and DNA damage‐regulated protein 1</td>
                        <td align="left" rowspan="1" colspan="1">−0.1765</td>
                        <td align="left" rowspan="1" colspan="1">1.42 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.0739</td>
                        <td align="left" rowspan="1" colspan="1">2.58 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.1159</td>
                        <td align="left" rowspan="1" colspan="1">5.03 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">1.92 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96CG8</td>
                        <td align="left" rowspan="1" colspan="1">CTHRC1</td>
                        <td align="left" rowspan="1" colspan="1">Collagen triple helix repeat‐containing protein 1</td>
                        <td align="left" rowspan="1" colspan="1">0.0772</td>
                        <td align="left" rowspan="1" colspan="1">2.06 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1066</td>
                        <td align="left" rowspan="1" colspan="1">1.05 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0947</td>
                        <td align="left" rowspan="1" colspan="1">6.53 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">2.29 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96KN2</td>
                        <td align="left" rowspan="1" colspan="1">CNDP1</td>
                        <td align="left" rowspan="1" colspan="1">β‐Ala‐His dipeptidase</td>
                        <td align="left" rowspan="1" colspan="1">0.1677</td>
                        <td align="left" rowspan="1" colspan="1">8.21 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1671</td>
                        <td align="left" rowspan="1" colspan="1">3.23 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1673</td>
                        <td align="left" rowspan="1" colspan="1">6.65 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">2.29 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P03951</td>
                        <td align="left" rowspan="1" colspan="1">F11</td>
                        <td align="left" rowspan="1" colspan="1">Coagulation factor XI</td>
                        <td align="left" rowspan="1" colspan="1">0.1109</td>
                        <td align="left" rowspan="1" colspan="1">5.82 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0991</td>
                        <td align="left" rowspan="1" colspan="1">4.81 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1031</td>
                        <td align="left" rowspan="1" colspan="1">7.35 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">2.42 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P43652</td>
                        <td align="left" rowspan="1" colspan="1">AFM</td>
                        <td align="left" rowspan="1" colspan="1">Afamin</td>
                        <td align="left" rowspan="1" colspan="1">−0.0987</td>
                        <td align="left" rowspan="1" colspan="1">3.42 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0770</td>
                        <td align="left" rowspan="1" colspan="1">7.67 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0838</td>
                        <td align="left" rowspan="1" colspan="1">7.85 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">2.47 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P35858</td>
                        <td align="left" rowspan="1" colspan="1">IGFALS</td>
                        <td align="left" rowspan="1" colspan="1">Insulin‐like growth factor‐binding protein complex acid labile subunit</td>
                        <td align="left" rowspan="1" colspan="1">0.0969</td>
                        <td align="left" rowspan="1" colspan="1">7.33 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0695</td>
                        <td align="left" rowspan="1" colspan="1">4.93 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0813</td>
                        <td align="left" rowspan="1" colspan="1">1.17 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">3.53 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O15031</td>
                        <td align="left" rowspan="1" colspan="1">PLXNB2</td>
                        <td align="left" rowspan="1" colspan="1">Plexin‐B2</td>
                        <td align="left" rowspan="1" colspan="1">0.1179</td>
                        <td align="left" rowspan="1" colspan="1">3.16 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0786</td>
                        <td align="left" rowspan="1" colspan="1">1.90 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0899</td>
                        <td align="left" rowspan="1" colspan="1">2.23 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">6.45 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q99536</td>
                        <td align="left" rowspan="1" colspan="1">VAT1</td>
                        <td align="left" rowspan="1" colspan="1">Synaptic vesicle membrane protein VAT‐1 homolog</td>
                        <td align="left" rowspan="1" colspan="1">−0.4338</td>
                        <td align="left" rowspan="1" colspan="1">4.92 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.1611</td>
                        <td align="left" rowspan="1" colspan="1">2.18 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.2031</td>
                        <td align="left" rowspan="1" colspan="1">2.37 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">6.59 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P00797</td>
                        <td align="left" rowspan="1" colspan="1">REN</td>
                        <td align="left" rowspan="1" colspan="1">Renin</td>
                        <td align="left" rowspan="1" colspan="1">0.2458</td>
                        <td align="left" rowspan="1" colspan="1">9.20 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.2482</td>
                        <td align="left" rowspan="1" colspan="1">1.06 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.2473</td>
                        <td align="left" rowspan="1" colspan="1">2.46 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">6.60 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P02753</td>
                        <td align="left" rowspan="1" colspan="1">RBP4</td>
                        <td align="left" rowspan="1" colspan="1">Retinol‐binding protein 4</td>
                        <td align="left" rowspan="1" colspan="1">0.0704</td>
                        <td align="left" rowspan="1" colspan="1">1.46 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1181</td>
                        <td align="left" rowspan="1" colspan="1">7.36 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.1052</td>
                        <td align="left" rowspan="1" colspan="1">2.91 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">7.54 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P08476</td>
                        <td align="left" rowspan="1" colspan="1">INHBA</td>
                        <td align="left" rowspan="1" colspan="1">Activin A</td>
                        <td align="left" rowspan="1" colspan="1">−0.1413</td>
                        <td align="left" rowspan="1" colspan="1">2.37 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.1325</td>
                        <td align="left" rowspan="1" colspan="1">6.05 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.1349</td>
                        <td align="left" rowspan="1" colspan="1">3.48 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">8.70 E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O00161</td>
                        <td align="left" rowspan="1" colspan="1">SNAP23</td>
                        <td align="left" rowspan="1" colspan="1">Synaptosomal‐associated protein 23</td>
                        <td align="left" rowspan="1" colspan="1">−0.0444</td>
                        <td align="left" rowspan="1" colspan="1">6.74 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.1286</td>
                        <td align="left" rowspan="1" colspan="1">4.28 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.1219</td>
                        <td align="left" rowspan="1" colspan="1">4.33 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">1.04 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P43652</td>
                        <td align="left" rowspan="1" colspan="1">AFM</td>
                        <td align="left" rowspan="1" colspan="1">Afamin</td>
                        <td align="left" rowspan="1" colspan="1">−0.0778</td>
                        <td align="left" rowspan="1" colspan="1">2.80 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.0801</td>
                        <td align="left" rowspan="1" colspan="1">7.77 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0794</td>
                        <td align="left" rowspan="1" colspan="1">5.21 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">1.22 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O75356</td>
                        <td align="left" rowspan="1" colspan="1">ENTPD5</td>
                        <td align="left" rowspan="1" colspan="1">Ectonucleoside triphosphate diphosphohydrolase 5</td>
                        <td align="left" rowspan="1" colspan="1">0.1311</td>
                        <td align="left" rowspan="1" colspan="1">9.12 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0682</td>
                        <td align="left" rowspan="1" colspan="1">1.13 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0884</td>
                        <td align="left" rowspan="1" colspan="1">6.23 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">1.41 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P49221</td>
                        <td align="left" rowspan="1" colspan="1">TGM4</td>
                        <td align="left" rowspan="1" colspan="1">Protein‐glutamine gamma‐glutamyltransferase 4</td>
                        <td align="left" rowspan="1" colspan="1">−0.1439</td>
                        <td align="left" rowspan="1" colspan="1">1.01 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1000</td>
                        <td align="left" rowspan="1" colspan="1">2.21 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.1222</td>
                        <td align="left" rowspan="1" colspan="1">6.71 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">1.47 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9Y5C1</td>
                        <td align="left" rowspan="1" colspan="1">ANGPTL3</td>
                        <td align="left" rowspan="1" colspan="1">Angiopoietin‐related protein 3</td>
                        <td align="left" rowspan="1" colspan="1">−0.1086</td>
                        <td align="left" rowspan="1" colspan="1">8.54 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1008</td>
                        <td align="left" rowspan="1" colspan="1">3.57 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1041</td>
                        <td align="left" rowspan="1" colspan="1">7.74 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">1.65 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96MU8</td>
                        <td align="left" rowspan="1" colspan="1">KREMEN1</td>
                        <td align="left" rowspan="1" colspan="1">Kremen protein 1</td>
                        <td align="left" rowspan="1" colspan="1">0.0624</td>
                        <td align="left" rowspan="1" colspan="1">3.67 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0714</td>
                        <td align="left" rowspan="1" colspan="1">9.42 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0683</td>
                        <td align="left" rowspan="1" colspan="1">8.39 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">1.74 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P00533</td>
                        <td align="left" rowspan="1" colspan="1">EGFR</td>
                        <td align="left" rowspan="1" colspan="1">Epidermal growth factor receptor</td>
                        <td align="left" rowspan="1" colspan="1">0.0564</td>
                        <td align="left" rowspan="1" colspan="1">2.12 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0544</td>
                        <td align="left" rowspan="1" colspan="1">1.99 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0551</td>
                        <td align="left" rowspan="1" colspan="1">1.03 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.08 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9UGP4</td>
                        <td align="left" rowspan="1" colspan="1">LIMD1</td>
                        <td align="left" rowspan="1" colspan="1">LIM domain‐containing protein 1</td>
                        <td align="left" rowspan="1" colspan="1">0.0692</td>
                        <td align="left" rowspan="1" colspan="1">2.11 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1089</td>
                        <td align="left" rowspan="1" colspan="1">2.65 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1000</td>
                        <td align="left" rowspan="1" colspan="1">1.24 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.37 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q8IVM0</td>
                        <td align="left" rowspan="1" colspan="1">CCDC50</td>
                        <td align="left" rowspan="1" colspan="1">Coiled‐coil domain‐containing protein 50</td>
                        <td align="left" rowspan="1" colspan="1">0.0706</td>
                        <td align="left" rowspan="1" colspan="1">3.00 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1909</td>
                        <td align="left" rowspan="1" colspan="1">8.71 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.1507</td>
                        <td align="left" rowspan="1" colspan="1">1.25 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.37 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P14207</td>
                        <td align="left" rowspan="1" colspan="1">FOLR2</td>
                        <td align="left" rowspan="1" colspan="1">Folate receptor β</td>
                        <td align="left" rowspan="1" colspan="1">0.0686</td>
                        <td align="left" rowspan="1" colspan="1">6.06 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0868</td>
                        <td align="left" rowspan="1" colspan="1">8.76 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0807</td>
                        <td align="left" rowspan="1" colspan="1">1.30 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.42 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q7L266</td>
                        <td align="left" rowspan="1" colspan="1">ASRGL1</td>
                        <td align="left" rowspan="1" colspan="1">Isoaspartyl peptidase/L‐asparaginase</td>
                        <td align="left" rowspan="1" colspan="1">−0.0547</td>
                        <td align="left" rowspan="1" colspan="1">4.29 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.0408</td>
                        <td align="left" rowspan="1" colspan="1">1.19 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0432</td>
                        <td align="left" rowspan="1" colspan="1">1.34 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.42 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q5H8A3</td>
                        <td align="left" rowspan="1" colspan="1">NMS</td>
                        <td align="left" rowspan="1" colspan="1">Neuromedin‐S</td>
                        <td align="left" rowspan="1" colspan="1">0.0298</td>
                        <td align="left" rowspan="1" colspan="1">3.48 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1108</td>
                        <td align="left" rowspan="1" colspan="1">3.61 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">0.0774</td>
                        <td align="left" rowspan="1" colspan="1">1.40 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.48 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96CA5</td>
                        <td align="left" rowspan="1" colspan="1">BIRC7</td>
                        <td align="left" rowspan="1" colspan="1">Baculoviral inhibitor of apoptosis domain repeat‐containing protein 7 isoform β</td>
                        <td align="left" rowspan="1" colspan="1">−0.0208</td>
                        <td align="left" rowspan="1" colspan="1">2.54 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.0559</td>
                        <td align="left" rowspan="1" colspan="1">1.03 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0425</td>
                        <td align="left" rowspan="1" colspan="1">1.48 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.55 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9Y5Y7</td>
                        <td align="left" rowspan="1" colspan="1">LYVE1</td>
                        <td align="left" rowspan="1" colspan="1">Lymphatic vessel endothelial hyaluronic acid receptor 1</td>
                        <td align="left" rowspan="1" colspan="1">0.0949</td>
                        <td align="left" rowspan="1" colspan="1">4.35 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0972</td>
                        <td align="left" rowspan="1" colspan="1">1.50 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0965</td>
                        <td align="left" rowspan="1" colspan="1">1.52 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.55 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q86U17</td>
                        <td align="left" rowspan="1" colspan="1">SERPINA11</td>
                        <td align="left" rowspan="1" colspan="1">Serpin A11</td>
                        <td align="left" rowspan="1" colspan="1">−0.1544</td>
                        <td align="left" rowspan="1" colspan="1">1.51 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.0913</td>
                        <td align="left" rowspan="1" colspan="1">3.06 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1033</td>
                        <td align="left" rowspan="1" colspan="1">1.76 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P48304</td>
                        <td align="left" rowspan="1" colspan="1">REG1B</td>
                        <td align="left" rowspan="1" colspan="1">Lithostathine‐1‐β</td>
                        <td align="left" rowspan="1" colspan="1">0.0765</td>
                        <td align="left" rowspan="1" colspan="1">2.17 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1521</td>
                        <td align="left" rowspan="1" colspan="1">2.73 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.1287</td>
                        <td align="left" rowspan="1" colspan="1">1.83 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96AH0</td>
                        <td align="left" rowspan="1" colspan="1">NABP1</td>
                        <td align="left" rowspan="1" colspan="1">Sensor of single‐strand DNA complex subunit B2</td>
                        <td align="left" rowspan="1" colspan="1">0.0813</td>
                        <td align="left" rowspan="1" colspan="1">6.48 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0970</td>
                        <td align="left" rowspan="1" colspan="1">1.21 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0921</td>
                        <td align="left" rowspan="1" colspan="1">1.84 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P11226</td>
                        <td align="left" rowspan="1" colspan="1">MBL2</td>
                        <td align="left" rowspan="1" colspan="1">Mannose‐binding protein C</td>
                        <td align="left" rowspan="1" colspan="1">−0.3164</td>
                        <td align="left" rowspan="1" colspan="1">6.48 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.2090</td>
                        <td align="left" rowspan="1" colspan="1">8.86 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.2437</td>
                        <td align="left" rowspan="1" colspan="1">1.93 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">2.98 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P08581</td>
                        <td align="left" rowspan="1" colspan="1">MET</td>
                        <td align="left" rowspan="1" colspan="1">Hepatocyte growth factor receptor</td>
                        <td align="left" rowspan="1" colspan="1">0.0737</td>
                        <td align="left" rowspan="1" colspan="1">2.38 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0798</td>
                        <td align="left" rowspan="1" colspan="1">3.54 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0773</td>
                        <td align="left" rowspan="1" colspan="1">2.06 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.11 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q5UCC4</td>
                        <td align="left" rowspan="1" colspan="1">EMC10</td>
                        <td align="left" rowspan="1" colspan="1">UPF0510 protein INM02</td>
                        <td align="left" rowspan="1" colspan="1">−0.0909</td>
                        <td align="left" rowspan="1" colspan="1">1.23 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0298</td>
                        <td align="left" rowspan="1" colspan="1">1.03 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.0531</td>
                        <td align="left" rowspan="1" colspan="1">2.14 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.17 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P01042</td>
                        <td align="left" rowspan="1" colspan="1">KNG1</td>
                        <td align="left" rowspan="1" colspan="1">Kininostatin</td>
                        <td align="left" rowspan="1" colspan="1">−0.1196</td>
                        <td align="left" rowspan="1" colspan="1">3.62 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.3739</td>
                        <td align="left" rowspan="1" colspan="1">2.09 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">0.2456</td>
                        <td align="left" rowspan="1" colspan="1">2.35 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.40 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q13093</td>
                        <td align="left" rowspan="1" colspan="1">PLA2G7</td>
                        <td align="left" rowspan="1" colspan="1">Platelet‐activating factor acetylhydrolase</td>
                        <td align="left" rowspan="1" colspan="1">−0.1118</td>
                        <td align="left" rowspan="1" colspan="1">7.82 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.1169</td>
                        <td align="left" rowspan="1" colspan="1">1.48 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.1156</td>
                        <td align="left" rowspan="1" colspan="1">2.56 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.63 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96GK7</td>
                        <td align="left" rowspan="1" colspan="1">FAHD2A</td>
                        <td align="left" rowspan="1" colspan="1">Fumarylacetoacetate hydrolase domain‐containing protein 2A</td>
                        <td align="left" rowspan="1" colspan="1">0.1745</td>
                        <td align="left" rowspan="1" colspan="1">1.23 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0927</td>
                        <td align="left" rowspan="1" colspan="1">5.10 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1288</td>
                        <td align="left" rowspan="1" colspan="1">2.73 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.72 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O14793</td>
                        <td align="left" rowspan="1" colspan="1">MSTN</td>
                        <td align="left" rowspan="1" colspan="1">Growth/differentiation factor 8</td>
                        <td align="left" rowspan="1" colspan="1">−0.1161</td>
                        <td align="left" rowspan="1" colspan="1">9.58 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0622</td>
                        <td align="left" rowspan="1" colspan="1">6.19 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0733</td>
                        <td align="left" rowspan="1" colspan="1">2.74 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.72 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P05451</td>
                        <td align="left" rowspan="1" colspan="1">REG1A</td>
                        <td align="left" rowspan="1" colspan="1">Lithostathine‐1‐α</td>
                        <td align="left" rowspan="1" colspan="1">0.1306</td>
                        <td align="left" rowspan="1" colspan="1">4.87 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1446</td>
                        <td align="left" rowspan="1" colspan="1">2.43 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1398</td>
                        <td align="left" rowspan="1" colspan="1">2.77 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.72 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NR71</td>
                        <td align="left" rowspan="1" colspan="1">ASAH2</td>
                        <td align="left" rowspan="1" colspan="1">Neutral ceramidase</td>
                        <td align="left" rowspan="1" colspan="1">0.1354</td>
                        <td align="left" rowspan="1" colspan="1">4.93 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1430</td>
                        <td align="left" rowspan="1" colspan="1">2.58 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1406</td>
                        <td align="left" rowspan="1" colspan="1">2.95 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">3.88 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P22352</td>
                        <td align="left" rowspan="1" colspan="1">GPX3</td>
                        <td align="left" rowspan="1" colspan="1">Glutathione peroxidase 3</td>
                        <td align="left" rowspan="1" colspan="1">0.0789</td>
                        <td align="left" rowspan="1" colspan="1">7.37 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0521</td>
                        <td align="left" rowspan="1" colspan="1">1.33 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0612</td>
                        <td align="left" rowspan="1" colspan="1">3.19 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.08 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q16787</td>
                        <td align="left" rowspan="1" colspan="1">LAMA3</td>
                        <td align="left" rowspan="1" colspan="1">Laminin subunit α‐3</td>
                        <td align="left" rowspan="1" colspan="1">−0.1318</td>
                        <td align="left" rowspan="1" colspan="1">3.00 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0613</td>
                        <td align="left" rowspan="1" colspan="1">1.59 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">−0.0788</td>
                        <td align="left" rowspan="1" colspan="1">3.21 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.08 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P55103</td>
                        <td align="left" rowspan="1" colspan="1">INHBC</td>
                        <td align="left" rowspan="1" colspan="1">Inhibin β C chain</td>
                        <td align="left" rowspan="1" colspan="1">−0.2466</td>
                        <td align="left" rowspan="1" colspan="1">1.51 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0764</td>
                        <td align="left" rowspan="1" colspan="1">1.17 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.1388</td>
                        <td align="left" rowspan="1" colspan="1">3.33 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.16 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96FC7</td>
                        <td align="left" rowspan="1" colspan="1">PHYHIPL</td>
                        <td align="left" rowspan="1" colspan="1">Phytanoyl‐CoA hydroxylase‐interacting protein‐like</td>
                        <td align="left" rowspan="1" colspan="1">0.1956</td>
                        <td align="left" rowspan="1" colspan="1">3.55 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">0.0737</td>
                        <td align="left" rowspan="1" colspan="1">1.20 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">0.1267</td>
                        <td align="left" rowspan="1" colspan="1">3.62 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.44 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q86Z14</td>
                        <td align="left" rowspan="1" colspan="1">KLB</td>
                        <td align="left" rowspan="1" colspan="1">β‐klotho</td>
                        <td align="left" rowspan="1" colspan="1">0.1431</td>
                        <td align="left" rowspan="1" colspan="1">5.27 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0758</td>
                        <td align="left" rowspan="1" colspan="1">1.52 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0942</td>
                        <td align="left" rowspan="1" colspan="1">3.82 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.61 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O15444</td>
                        <td align="left" rowspan="1" colspan="1">CCL25</td>
                        <td align="left" rowspan="1" colspan="1">C‐C motif chemokine 25</td>
                        <td align="left" rowspan="1" colspan="1">−0.2705</td>
                        <td align="left" rowspan="1" colspan="1">1.24 E‐06</td>
                        <td align="left" rowspan="1" colspan="1">−0.0355</td>
                        <td align="left" rowspan="1" colspan="1">2.99 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.1025</td>
                        <td align="left" rowspan="1" colspan="1">3.92 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.65 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9H4D0</td>
                        <td align="left" rowspan="1" colspan="1">CLSTN2</td>
                        <td align="left" rowspan="1" colspan="1">Calsyntenin‐2</td>
                        <td align="left" rowspan="1" colspan="1">0.0021</td>
                        <td align="left" rowspan="1" colspan="1">9.71 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.1071</td>
                        <td align="left" rowspan="1" colspan="1">1.04 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0876</td>
                        <td align="left" rowspan="1" colspan="1">4.02 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.70 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P13725</td>
                        <td align="left" rowspan="1" colspan="1">OSM</td>
                        <td align="left" rowspan="1" colspan="1">Oncostatin‐M</td>
                        <td align="left" rowspan="1" colspan="1">−0.1646</td>
                        <td align="left" rowspan="1" colspan="1">5.45 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0680</td>
                        <td align="left" rowspan="1" colspan="1">9.63 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0841</td>
                        <td align="left" rowspan="1" colspan="1">4.31 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P62072</td>
                        <td align="left" rowspan="1" colspan="1">TIMM10</td>
                        <td align="left" rowspan="1" colspan="1">Mitochondrial import inner membrane translocase subunit Tim10</td>
                        <td align="left" rowspan="1" colspan="1">0.1451</td>
                        <td align="left" rowspan="1" colspan="1">1.27 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0864</td>
                        <td align="left" rowspan="1" colspan="1">9.22 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1009</td>
                        <td align="left" rowspan="1" colspan="1">4.33 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q15884</td>
                        <td align="left" rowspan="1" colspan="1">FAM189A2</td>
                        <td align="left" rowspan="1" colspan="1">Protein FAM189A2</td>
                        <td align="left" rowspan="1" colspan="1">0.1753</td>
                        <td align="left" rowspan="1" colspan="1">1.28 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1236</td>
                        <td align="left" rowspan="1" colspan="1">1.17 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1405</td>
                        <td align="left" rowspan="1" colspan="1">4.41 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q92820</td>
                        <td align="left" rowspan="1" colspan="1">GGH</td>
                        <td align="left" rowspan="1" colspan="1">γ‐glutamyl hydrolase</td>
                        <td align="left" rowspan="1" colspan="1">−0.0143</td>
                        <td align="left" rowspan="1" colspan="1">6.58 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.0953</td>
                        <td align="left" rowspan="1" colspan="1">6.71 E‐05</td>
                        <td align="left" rowspan="1" colspan="1">−0.0669</td>
                        <td align="left" rowspan="1" colspan="1">4.48 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9Y279</td>
                        <td align="left" rowspan="1" colspan="1">VSIG4</td>
                        <td align="left" rowspan="1" colspan="1">V‐set and immunoglobulin domain‐containing protein 4</td>
                        <td align="left" rowspan="1" colspan="1">0.0898</td>
                        <td align="left" rowspan="1" colspan="1">7.43 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.1153</td>
                        <td align="left" rowspan="1" colspan="1">2.52 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.1060</td>
                        <td align="left" rowspan="1" colspan="1">4.53 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P04114</td>
                        <td align="left" rowspan="1" colspan="1">APOB</td>
                        <td align="left" rowspan="1" colspan="1">Apolipoprotein B</td>
                        <td align="left" rowspan="1" colspan="1">−0.0069</td>
                        <td align="left" rowspan="1" colspan="1">9.75 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.2855</td>
                        <td align="left" rowspan="1" colspan="1">2.49 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.2550</td>
                        <td align="left" rowspan="1" colspan="1">4.65 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O15444</td>
                        <td align="left" rowspan="1" colspan="1">CCL25</td>
                        <td align="left" rowspan="1" colspan="1">C‐C motif chemokine 25</td>
                        <td align="left" rowspan="1" colspan="1">−0.2144</td>
                        <td align="left" rowspan="1" colspan="1">1.02 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">−0.0565</td>
                        <td align="left" rowspan="1" colspan="1">1.22 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.1056</td>
                        <td align="left" rowspan="1" colspan="1">4.67 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.90 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P03952</td>
                        <td align="left" rowspan="1" colspan="1">KLKB1</td>
                        <td align="left" rowspan="1" colspan="1">Plasma kallikrein</td>
                        <td align="left" rowspan="1" colspan="1">0.0526</td>
                        <td align="left" rowspan="1" colspan="1">6.14 E‐02</td>
                        <td align="left" rowspan="1" colspan="1">0.0718</td>
                        <td align="left" rowspan="1" colspan="1">3.02 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">0.0636</td>
                        <td align="left" rowspan="1" colspan="1">4.86 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.96 E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P04217</td>
                        <td align="left" rowspan="1" colspan="1">A1BG</td>
                        <td align="left" rowspan="1" colspan="1">α‐1B‐glycoprotein</td>
                        <td align="left" rowspan="1" colspan="1">−0.0484</td>
                        <td align="left" rowspan="1" colspan="1">1.37 E‐01</td>
                        <td align="left" rowspan="1" colspan="1">−0.0716</td>
                        <td align="left" rowspan="1" colspan="1">1.45 E‐03</td>
                        <td align="left" rowspan="1" colspan="1">−0.0641</td>
                        <td align="left" rowspan="1" colspan="1">4.87 E‐04</td>
                        <td align="left" rowspan="1" colspan="1">4.96 E‐02</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38300-ntgp-0003">
                    <fn id="jah38300-note-0008">
                      <p>DASH indicates Dietary Approaches to Stop Hypertension; FDR, false discovery rate; and ID, identification.</p>
                    </fn>
                    <fn id="jah38300-note-0009">
                      <label>*</label>
                      <p><mml:math id="jats-math-1" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> and <italic toggle="yes">P</italic> values were calculated using multivariable linear regression models that were adjusted for age, sex, race and ethnicity, and body mass index in each study. Study‐specific <mml:math id="jats-math-2" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients and <italic toggle="yes">P</italic> values were meta‐analyzed across the DASH and DASH‐Sodium trials using a fixed‐effects model. Only proteins that were at FDR &lt;0.05 after meta‐analysis are presented. Positive <mml:math id="jats-math-3" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients indicate that the abundance of protein was higher in participants consuming the DASH diet relative to the control diet. Negative <mml:math id="jats-math-4" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients indicate that the abundance of protein was lower in participants consuming the DASH diet relative to the control diet.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <fig position="float" fig-type="Figure" id="jah38300-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <title>Volcano plots of <mml:math id="jats-math-5" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="bold">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients and false discovery rate (FDR)–adjusted <italic toggle="yes">P</italic> values for proteins differing significantly between the Dietary Approaches to Stop Hypertension (DASH) diet compared with the control diet in the DASH and DASH‐Sodium trials.</title>
                    <p>The dashed horizontal line represents FDR &lt;0.05, and the vertical dashed line is set at the <mml:math id="jats-math-6" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficient of 0. Proteins located to the right of the vertical line indicate that the abundance of proteins was higher in participants consuming the DASH compared with the control diet, and proteins located to the left of the vertical line indicate that the abundance of proteins was lower in participants consuming the DASH compared with the control diet. <mml:math id="jats-math-7" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> and <italic toggle="yes">P</italic> values were calculated using multivariable linear regression models that were adjusted for age, sex, race and ethnicity, and body mass index in each study. Estimates were meta‐analyzed across the DASH and DASH‐Sodium trials using fixed‐effects models. Study‐specific <mml:math id="jats-math-8" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients, <italic toggle="yes">P</italic> values, and the full name of all of these proteins are presented in Table <xref rid="jah38300-tbl-0002" ref-type="table">2</xref>.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e028821-g002" position="anchor" id="jats-graphic-1"/>
                </fig>
              </sec>
              <sec id="jah38300-sec-0019">
                <title>Proteins That Were Validated in the <styled-content style="fixed-case" toggle="no">ARIC</styled-content> Study</title>
                <p>Out of 71 proteins, 50 proteins were available in the ARIC study. Of the 50 proteins analyzed, 19 proteins were validated in the ARIC study at a statistically significant threshold of FDR &lt;0.05 and with the same direction of association as the DASH and DASH‐Sodium trials (Figure <xref rid="jah38300-fig-0002" ref-type="fig">2</xref>; Table <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S2</xref>). The magnitude of the association between proteins and the DASH diet score was smaller in the ARIC study compared with the DASH trials (Figure <xref rid="jah38300-fig-0002" ref-type="fig">2</xref>). Eleven proteins (CD163 [scavenger receptor cysteine‐rich type 1 protein M130], ASHA2 [neutral ceramidase], PCOLCE [procollagen C‐endopeptidase enhancer 1], RBP4 [retinol‐binding protein 4], LYVE1 [lymphatic vessel endothelial hyaluronic acid receptor 1], CTHRC1 [collagen triple helix repeat‐containing protein 1], S100A14 [protein S100‐A14], FOLR2, MET [hepatocyte growth factor receptor], KREMEN1 [kremen protein 1], and EGFR) were positively associated with the DASH diet score, and 8 proteins (GGH, AFM, PGLYRP2, CCL25 [C‐C motif chemokine 25], PDRG1 [p53 and DNA damage‐regulated protein 1], INHBA, INHBC [inhibin β C chain], and VAT1 [synaptic vesicle membrane protein VAT‐1 homolog]) were negatively associated with the DASH diet score.</p>
                <fig position="float" fig-type="Figures" id="jah38300-fig-0002">
                  <label>Figures 2</label>
                  <caption>
                    <title><mml:math id="jats-math-9" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="bold">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients and 95% CIs of 19 proteins that were significantly different between the Dietary Approaches to Stop Hypertension (DASH) diet and the control diet in the trials (DASH trial [N=215] and DASH‐Sodium trial [N=396]) (left panel) and were validated using the DASH diet score in the ARIC (Atherosclerosis Risk in Communities) study (N=10 490) (right panel).</title>
                    <p>In the DASH and DASH‐Sodium trials, <mml:math id="jats-math-10" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients and 95% CIs were calculated using multivariable linear regression models, adjusting for age, sex, race and ethnicity, and body mass index. Estimates were meta‐analyzed across the 2 trials using fixed‐effects models. In the ARIC study, <mml:math id="jats-math-11" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">β</mml:mi></mml:mrow></mml:mrow></mml:math> coefficients and 95% CIs were calculated using multivariable linear regression models that were adjusted for age, sex, race, study center, education level, alcohol drinking status, cigarette smoking status, physical activity score, body mass index, diabetes status, and estimated glomerular filtration rate. AFM indicates afamin; ASAH2, neutral ceramidase; CCL25, C‐C motif chemokine 25; CD163, scavenger receptor cysteine‐rich type 1 protein M130; CTHRC1, collagen triple helix repeat‐containing protein 1; EGFR, epidermal growth factor receptor; FOLR2, folate receptor β; GGH, γ‐glutamyl hydrolase; INHBA, inhibin β A chain; INHBC, inhibin β C chain; KREMEN1, kremen protein 1; LYVE1, lymphatic vessel endothelial hyaluronic acid receptor 1; MET, hepatocyte growth factor receptor; PCOLCE, procollagen C‐endopeptidase enhancer 1; PDRG1, p53 and DNA damage‐regulated protein 1; PGLYRP2, N‐acetylmuramoyl‐L‐alanine amidase; RBP4, retinol‐binding protein 4; S100A14, protein S100‐A14; and VAT1, synaptic vesicle membrane protein VAT‐1 homolog.</p>
                  </caption>
                  <graphic xlink:href="JAH3-12-e028821-g001" position="anchor" id="jats-graphic-3"/>
                </fig>
              </sec>
              <sec id="jah38300-sec-0020">
                <title>Prediction of the <styled-content style="fixed-case" toggle="no">DASH</styled-content> Diet in the <styled-content style="fixed-case" toggle="no">DASH</styled-content> and <styled-content style="fixed-case" toggle="no">DASH‐Sodium</styled-content> Trials and the <styled-content style="fixed-case" toggle="no">ARIC</styled-content> Study</title>
                <p>PCOLCE, INHBA, VAT1, and AFM significantly improved the prediction of the DASH diet beyond the participant characteristics in both trials (range of difference in C statistics, 0.037–0.082; <italic toggle="yes">P</italic>&lt;0.001 for all tests) (Table <xref rid="jah38300-tbl-0003" ref-type="table">3</xref>). Collectively, the 19 validated proteins significantly improved the prediction of the DASH diet in the DASH trial (difference in C statistics, 0.313; <italic toggle="yes">P</italic>&lt;0.001), DASH‐Sodium trial (difference in C statistics, 0.267; <italic toggle="yes">P</italic>&lt;0.001), and modestly in the ARIC study (C statistic for participant characteristics, 0.698; C statistic for 19 proteins and participant characteristics, 0.715; difference in C statistics, 0.017; <italic toggle="yes">P</italic>&lt;0.001).</p>
                <table-wrap position="float" id="jah38300-tbl-0003" content-type="Table">
                  <label>Table 3</label>
                  <caption>
                    <p>Prediction of the DASH Dietary Pattern Using 19 Proteins That Were Statistically Significant in the DASH and DASH‐Sodium Trials and Replicated in the ARIC Study<xref rid="jah38300-note-0011" ref-type="table-fn">*</xref>
</p>
                  </caption>
                  <table frame="hsides" rules="all">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">UniProt ID</th>
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Entrezgene symbol</th>
                        <th align="left" rowspan="2" style="border-bottom:solid 1px #000000" colspan="1">Protein name</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">DASH trial<xref rid="jah38300-note-0012" ref-type="table-fn">†</xref>
<sup>,</sup>
<xref rid="jah38300-note-0013" ref-type="table-fn">‡</xref>
</th>
                        <th align="left" colspan="3" style="border-bottom:solid 1px #000000" rowspan="1">DASH‐Sodium trial<xref rid="jah38300-note-0012" ref-type="table-fn">†</xref>
<sup>,</sup>
<xref rid="jah38300-note-0013" ref-type="table-fn">‡</xref>
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">C statistics for protein+participant characteristics</th>
                        <th align="left" rowspan="1" colspan="1">Difference in C statistics</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th>
                        <th align="left" rowspan="1" colspan="1">C statistics for protein+participant characteristics</th>
                        <th align="left" rowspan="1" colspan="1">Difference in C statistics</th>
                        <th align="left" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q15113<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">PCOLCE<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Procollagen C‐endopeptidase enhancer 1<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.608<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.044<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.653<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.063<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NUG6</td>
                        <td align="left" rowspan="1" colspan="1">PDRG1</td>
                        <td align="left" rowspan="1" colspan="1">p53 and DNA damage‐regulated protein 1</td>
                        <td align="left" rowspan="1" colspan="1">0.678</td>
                        <td align="left" rowspan="1" colspan="1">0.103</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.604</td>
                        <td align="left" rowspan="1" colspan="1">0.028</td>
                        <td align="left" rowspan="1" colspan="1">0.12</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P08476<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">INHBA<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Inhibin β A chain<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.651<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.077<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.621<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.045<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96CG8</td>
                        <td align="left" rowspan="1" colspan="1">CTHRC1</td>
                        <td align="left" rowspan="1" colspan="1">Collagen triple helix repeat‐containing protein 1</td>
                        <td align="left" rowspan="1" colspan="1">0.603</td>
                        <td align="left" rowspan="1" colspan="1">0.043</td>
                        <td align="left" rowspan="1" colspan="1">0.08</td>
                        <td align="left" rowspan="1" colspan="1">0.645</td>
                        <td align="left" rowspan="1" colspan="1">0.054</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P14207</td>
                        <td align="left" rowspan="1" colspan="1">FOLR2</td>
                        <td align="left" rowspan="1" colspan="1">Folate receptor β</td>
                        <td align="left" rowspan="1" colspan="1">0.598</td>
                        <td align="left" rowspan="1" colspan="1">0.030</td>
                        <td align="left" rowspan="1" colspan="1">0.2</td>
                        <td align="left" rowspan="1" colspan="1">0.625</td>
                        <td align="left" rowspan="1" colspan="1">0.044</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P02753</td>
                        <td align="left" rowspan="1" colspan="1">RBP4</td>
                        <td align="left" rowspan="1" colspan="1">Retinol‐binding protein 4</td>
                        <td align="left" rowspan="1" colspan="1">0.580</td>
                        <td align="left" rowspan="1" colspan="1">0.027</td>
                        <td align="left" rowspan="1" colspan="1">0.18</td>
                        <td align="left" rowspan="1" colspan="1">0.635</td>
                        <td align="left" rowspan="1" colspan="1">0.053</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P55103</td>
                        <td align="left" rowspan="1" colspan="1">INHBC</td>
                        <td align="left" rowspan="1" colspan="1">Inhibin β C chain</td>
                        <td align="left" rowspan="1" colspan="1">0.638</td>
                        <td align="left" rowspan="1" colspan="1">0.071</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.588</td>
                        <td align="left" rowspan="1" colspan="1">0.020</td>
                        <td align="left" rowspan="1" colspan="1">0.24</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96MU8</td>
                        <td align="left" rowspan="1" colspan="1">KREMEN1</td>
                        <td align="left" rowspan="1" colspan="1">Kremen protein 1</td>
                        <td align="left" rowspan="1" colspan="1">0.625</td>
                        <td align="left" rowspan="1" colspan="1">0.049</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                        <td align="left" rowspan="1" colspan="1">0.623</td>
                        <td align="left" rowspan="1" colspan="1">0.039</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9HCY8</td>
                        <td align="left" rowspan="1" colspan="1">S100A14</td>
                        <td align="left" rowspan="1" colspan="1">Protein S100‐A14</td>
                        <td align="left" rowspan="1" colspan="1">0.618</td>
                        <td align="left" rowspan="1" colspan="1">0.041</td>
                        <td align="left" rowspan="1" colspan="1">0.1</td>
                        <td align="left" rowspan="1" colspan="1">0.652</td>
                        <td align="left" rowspan="1" colspan="1">0.069</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q99536<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">VAT1<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Synaptic vesicle membrane protein VAT‐1 homolog<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.666<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.082<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.614<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.037<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P00533</td>
                        <td align="left" rowspan="1" colspan="1">EGFR</td>
                        <td align="left" rowspan="1" colspan="1">Epidermal growth factor receptor</td>
                        <td align="left" rowspan="1" colspan="1">0.598</td>
                        <td align="left" rowspan="1" colspan="1">0.034</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                        <td align="left" rowspan="1" colspan="1">0.613</td>
                        <td align="left" rowspan="1" colspan="1">0.035</td>
                        <td align="left" rowspan="1" colspan="1">0.14</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">O15444</td>
                        <td align="left" rowspan="1" colspan="1">CCL25</td>
                        <td align="left" rowspan="1" colspan="1">C‐C motif chemokine 25</td>
                        <td align="left" rowspan="1" colspan="1">0.669</td>
                        <td align="left" rowspan="1" colspan="1">0.091</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.583</td>
                        <td align="left" rowspan="1" colspan="1">0.009</td>
                        <td align="left" rowspan="1" colspan="1">0.46</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P08581</td>
                        <td align="left" rowspan="1" colspan="1">MET</td>
                        <td align="left" rowspan="1" colspan="1">Hepatocyte growth factor receptor</td>
                        <td align="left" rowspan="1" colspan="1">0.611</td>
                        <td align="left" rowspan="1" colspan="1">0.040</td>
                        <td align="left" rowspan="1" colspan="1">0.08</td>
                        <td align="left" rowspan="1" colspan="1">0.624</td>
                        <td align="left" rowspan="1" colspan="1">0.043</td>
                        <td align="left" rowspan="1" colspan="1">0.1</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9Y5Y7</td>
                        <td align="left" rowspan="1" colspan="1">LYVE1</td>
                        <td align="left" rowspan="1" colspan="1">Lymphatic vessel endothelial hyaluronic acid receptor 1</td>
                        <td align="left" rowspan="1" colspan="1">0.593</td>
                        <td align="left" rowspan="1" colspan="1">0.038</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                        <td align="left" rowspan="1" colspan="1">0.611</td>
                        <td align="left" rowspan="1" colspan="1">0.030</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q9NR71</td>
                        <td align="left" rowspan="1" colspan="1">ASAH2</td>
                        <td align="left" rowspan="1" colspan="1">Neutral ceramidase</td>
                        <td align="left" rowspan="1" colspan="1">0.594</td>
                        <td align="left" rowspan="1" colspan="1">0.035</td>
                        <td align="left" rowspan="1" colspan="1">0.12</td>
                        <td align="left" rowspan="1" colspan="1">0.619</td>
                        <td align="left" rowspan="1" colspan="1">0.039</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">P43652<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">AFM<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Afamin<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.640<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.069<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.618<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.041<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001<xref rid="jah38300-note-0015" ref-type="table-fn">||</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q86VB7</td>
                        <td align="left" rowspan="1" colspan="1">CD163</td>
                        <td align="left" rowspan="1" colspan="1">Scavenger receptor cysteine‐rich type 1 protein M130</td>
                        <td align="left" rowspan="1" colspan="1">0.618</td>
                        <td align="left" rowspan="1" colspan="1">0.057</td>
                        <td align="left" rowspan="1" colspan="1">0.1</td>
                        <td align="left" rowspan="1" colspan="1">0.623</td>
                        <td align="left" rowspan="1" colspan="1">0.045</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q96PD5</td>
                        <td align="left" rowspan="1" colspan="1">PGLYRP2</td>
                        <td align="left" rowspan="1" colspan="1">N‐acetylmuramoyl‐L‐alanine amidase</td>
                        <td align="left" rowspan="1" colspan="1">0.645</td>
                        <td align="left" rowspan="1" colspan="1">0.089</td>
                        <td align="left" rowspan="1" colspan="1">0.04</td>
                        <td align="left" rowspan="1" colspan="1">0.629</td>
                        <td align="left" rowspan="1" colspan="1">0.044</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Q92820</td>
                        <td align="left" rowspan="1" colspan="1">GGH</td>
                        <td align="left" rowspan="1" colspan="1">γ‐glutamyl hydrolase</td>
                        <td align="left" rowspan="1" colspan="1">0.559</td>
                        <td align="left" rowspan="1" colspan="1">0.012</td>
                        <td align="left" rowspan="1" colspan="1">0.58</td>
                        <td align="left" rowspan="1" colspan="1">0.633</td>
                        <td align="left" rowspan="1" colspan="1">0.055</td>
                        <td align="left" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="3" rowspan="1">All 19 proteins<xref rid="jah38300-note-0014" ref-type="table-fn">§</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">0.867</td>
                        <td align="left" rowspan="1" colspan="1">0.313</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                        <td align="left" rowspan="1" colspan="1">0.837</td>
                        <td align="left" rowspan="1" colspan="1">0.267</td>
                        <td align="left" rowspan="1" colspan="1">&lt;0.001</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="jah38300-ntgp-0004">
                    <fn id="jah38300-note-0010">
                      <p>ARIC indicates Atherosclerosis Risk in Communities; DASH, Dietary Approaches to Stop Hypertension; ID, identification; and VAT1, synaptic vesicle membrane protein VAT‐1 homolog.</p>
                    </fn>
                    <fn id="jah38300-note-0011">
                      <label>*</label>
                      <p>C statistics for covariates only were 0.559 for the DASH trial and 0.577 for the DASH‐Sodium trial. We used logistic regression models to predict DASH diet intervention compared with the control diet intervention (response variable) using participant characteristics (age, sex, race and ethnicity, and body mass index) first, and investigated whether adding each of the proteins separately on top of the model with only the covariates improved the prediction of the DASH diet intervention.</p>
                    </fn>
                    <fn id="jah38300-note-0012">
                      <label>
                        <sup>†</sup>
                      </label>
                      <p>Difference in C statistics was calculated using 1000 bootstrapped samples and represents the difference in C statistics for a model with only the participant characteristics and a model with proteins and participant characteristics.</p>
                    </fn>
                    <fn id="jah38300-note-0013">
                      <label>
                        <sup>‡</sup>
                      </label>
                      <p><italic toggle="yes">P</italic> value comparing difference in C statistics for a model with only the participant characteristics and a model with proteins and participant characteristics.</p>
                    </fn>
                    <fn id="jah38300-note-0014">
                      <label>
                        <sup>§</sup>
                      </label>
                      <p>All 19 proteins were added to the model to assess whether they collectively improved the prediction of the DASH diet intervention.</p>
                    </fn>
                    <fn id="jah38300-note-0015">
                      <label>
                        <sup>||</sup>
                      </label>
                      <p>Indicates the 4 proteins that improved the prediction of the DASH diet in both the DASH and DASH‐Sodium trials.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>The direction and magnitude of the association between the 19 validated proteins and the DASH diet were similar for women and men, and there was no statistical evidence of interaction by sex (<italic toggle="yes">P</italic> for interaction &gt;0.05 for all tests; Table <xref rid="jah38300-supitem-0001" ref-type="supplementary-material">S3</xref>).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="jah38300-sec-0021">
              <title>Discussion</title>
              <p>In a large‐scale proteomic analysis of 2 randomized feeding studies of adults with pre‐ or stage 1 hypertension (systolic blood pressure &lt;160 mm Hg and diastolic blood pressure 80–95 mm Hg), 71 proteins were significantly different between the DASH and control diets. In an observational study, 19 of the 50 available proteins were validated as being associated with adherence to the DASH diet score, which represented the usual intake of the DASH diet. Rather than a single biomarker, we identified a panel of proteins in the blood that better capture the multidimensional nature of the DASH diet, supported by the greater magnitude of increase in C statistic for the 19 proteins collectively versus individual proteins. These 19 proteins significantly improved the prediction of the DASH diet in the DASH and DASH‐Sodium trials, and modestly in the ARIC study. If replicated in other study populations, these results support the use of 19 proteins as objective biomarkers of the DASH diet.</p>
              <p>Two of the 19 validated proteins (RBP4 and FOLR2), which were positively associated with the DASH diet, have well‐established relations with dietary intake. Retinoic acid (vitamin A), which can be derived from fruits and vegetables (carotenoids), directly binds to its cognate circulating protein (RBP4) and transthyretin, distributing vitamin A for cellular uptake.<xref rid="jah38300-bib-0030" ref-type="bibr"><sup>30</sup></xref> In a sample of 500 children in Nepal, plasma retinol concentration was strongly correlated with RBP4.<xref rid="jah38300-bib-0030" ref-type="bibr"><sup>30</sup></xref> FOLR2 binds to folate and reduces folic acid derivatives, and delivers 5‐methyltetrahydrofolate and folate analogs into the interior of cells.<xref rid="jah38300-bib-0031" ref-type="bibr"><sup>31</sup></xref> Compared with the control diet, the DASH diet was higher in vitamin A and folate. Furthermore, serum folate increased significantly after the DASH diet intervention, whereas serum folate declined after the control diet intervention in the DASH trial.<xref rid="jah38300-bib-0032" ref-type="bibr"><sup>32</sup></xref> Positive associations between the DASH diet, RBP4, and FOLR2 suggest that the DASH diet improved vitamin A and folate status.</p>
              <p>Prior studies reported an association between AFM and clinical outcomes. AFM is a vitamin‐E binding protein expressed in the liver, and is known as a carrier of hydrophobic molecules.<xref rid="jah38300-bib-0033" ref-type="bibr"><sup>33</sup></xref> However, plasma levels of AFM had significant or null associations with vitamin E status.<xref rid="jah38300-bib-0034" ref-type="bibr"><sup>34</sup></xref>, <xref rid="jah38300-bib-0035" ref-type="bibr"><sup>35</sup></xref> Several studies reported that circulating levels of AFM were positively associated with adiposity, metabolic syndrome, greater hepatic lipid content, and prevalent and incident type 2 diabetes.<xref rid="jah38300-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="jah38300-bib-0036" ref-type="bibr"><sup>36</sup></xref>, <xref rid="jah38300-bib-0037" ref-type="bibr"><sup>37</sup></xref>, <xref rid="jah38300-bib-0038" ref-type="bibr"><sup>38</sup></xref> The DASH diet had favorable effects on blood lipids and was associated with a lower risk of metabolic syndrome and type 2 diabetes.<xref rid="jah38300-bib-0039" ref-type="bibr"><sup>39</sup></xref>, <xref rid="jah38300-bib-0040" ref-type="bibr"><sup>40</sup></xref>, <xref rid="jah38300-bib-0041" ref-type="bibr"><sup>41</sup></xref>, <xref rid="jah38300-bib-0042" ref-type="bibr"><sup>42</sup></xref> Consistent with these observations, we found an inverse association between the DASH diet and AFM.</p>
              <p>Furthermore, EGFR has been associated with dietary intake and clinical outcomes. In 1662 participants of the Framingham Heart Study, greater adherence to self‐reported DASH diet, Alternative Healthy Eating Index, and Mediterranean‐style diet was positively associated with plasma EGFR levels, consistent with the findings from our study.<xref rid="jah38300-bib-0015" ref-type="bibr"><sup>15</sup></xref> EGFR is a membrane‐bound protein involved in cell metabolism and cell adhesion. Plasma EGFR has been associated with more stable plaque phenotype given its role in stimulation of smooth muscle cells, and was inversely associated with incident atrial fibrillation and coronary events.<xref rid="jah38300-bib-0043" ref-type="bibr"><sup>43</sup></xref>, <xref rid="jah38300-bib-0044" ref-type="bibr"><sup>44</sup></xref>
</p>
              <p>Four novel proteins (MET, ASAH2 [neutral ceramidase], PGLYRP2, CCL25] associated with the DASH diet in our study have a role in inflammation, suggesting an anti‐inflammatory effect of the DASH diet. MET regulates many physiological processes, including proliferation, scattering, morphogenesis, survival, and is essential for tissue repair.<xref rid="jah38300-bib-0045" ref-type="bibr"><sup>45</sup></xref> Interestingly, circulating MET levels have been proposed as biomarkers of atherosclerosis and stroke.<xref rid="jah38300-bib-0046" ref-type="bibr"><sup>46</sup></xref>, <xref rid="jah38300-bib-0047" ref-type="bibr"><sup>47</sup></xref> However, this protein is released in response to endothelial tissue injury and is considered both anti‐inflammatory and antifibrotic.<xref rid="jah38300-bib-0048" ref-type="bibr"><sup>48</sup></xref> In animal models, MET signaling regulated normal heart function by reducing oxidative stress.<xref rid="jah38300-bib-0049" ref-type="bibr"><sup>49</sup></xref> ASAH2, a secreted protein that hydrolyzes ceramides and dietary sphingolipids in the small intestine, was positively associated with the DASH diet in our study.<xref rid="jah38300-bib-0050" ref-type="bibr"><sup>50</sup></xref> One study of rat insulinoma cell line found that ASAH2 was released through exomes from insulinoma cells when concentration of cytokines was low, but ASAH2 release was inhibited when concentration of cytokines was high.<xref rid="jah38300-bib-0051" ref-type="bibr"><sup>51</sup></xref> CCL25, a chemokine secreted by various cells, was negatively associated with the DASH diet. CCL25 is known to play a role in immune regulation and inflammatory processes, and circulating levels of chemokines were proposed as biomarkers of cardiovascular disease.<xref rid="jah38300-bib-0052" ref-type="bibr"><sup>52</sup></xref>, <xref rid="jah38300-bib-0053" ref-type="bibr"><sup>53</sup></xref> Our findings for MET, ASAH2, and CCL25 supports the potential anti‐inflammatory effect of the DASH diet. PGLYRP2, also known as peptidoglycan recognition protein 2, is produced in the liver and is secreted into the blood.<xref rid="jah38300-bib-0054" ref-type="bibr"><sup>54</sup></xref> PGLYRP2 is thought to hydrolyze proinflammatory peptidoglycan.<xref rid="jah38300-bib-0054" ref-type="bibr"><sup>54</sup></xref> Plasma protein abundance of PGLYRP2 declined in mice after being fed high‐fat diet regimens (high in saturated fat, high in polyunsaturated fat) for 6 weeks.<xref rid="jah38300-bib-0055" ref-type="bibr"><sup>55</sup></xref> The results of our study are in contrast with this prior study in mice, given that blood PGLYRP2 concentrations were lower after the DASH diet intervention, which was lower in saturated fat than the control diet. However, the effect of PGLYRP2 on inflammation is inconclusive.<xref rid="jah38300-bib-0056" ref-type="bibr"><sup>56</sup></xref> The direction of association between the healthy dietary patterns and PGLYRP2 requires further investigation.</p>
              <p>We identified 3 additional proteins that were positively associated with the DASH diet (CTHRC1, LYVE1, and PCOLCE), which supports that the DASH diet lowers arterial stiffness,<xref rid="jah38300-bib-0057" ref-type="bibr"><sup>57</sup></xref> potentially by influencing collagen deposition. CTHRC1 is secreted in response to endothelial injury and acts as a negative regulator of collagen matrix deposition.<xref rid="jah38300-bib-0058" ref-type="bibr"><sup>58</sup></xref>, <xref rid="jah38300-bib-0059" ref-type="bibr"><sup>59</sup></xref> LYVE1 is a transporter of hyaluronic acid. In mouse and human aorta, macrophages that expressed LYVE1 degraded collagen in vascular smooth muscle cells.<xref rid="jah38300-bib-0060" ref-type="bibr"><sup>60</sup></xref> PCOLCE is a secretory glycoprotein that enhances procollagen C‐proteinase activity.<xref rid="jah38300-bib-0061" ref-type="bibr"><sup>61</sup></xref> Although PCOLCE has been suggested as a biomarker of fibrosis, PCOLCE is also involved in repairing injured tissue and plays an important role in regulation of collagen accumulation.<xref rid="jah38300-bib-0061" ref-type="bibr"><sup>61</sup></xref> The DASH diet is high in fruits and vegetables (rich in polyphenols), soy (isoflavones), and low‐fat dairy, which has been associated with lower arterial stiffening in humans.<xref rid="jah38300-bib-0062" ref-type="bibr"><sup>62</sup></xref>
</p>
              <p>Our finding of a positive association between CD163 and the DASH diet is inconsistent in its direction of association with previous research. CD163 is a transmembrane scavenger receptor protein that is expressed in macrophages and monocytes.<xref rid="jah38300-bib-0063" ref-type="bibr"><sup>63</sup></xref> During macrophage activation, CD163 sheds a soluble form. Circulating CD163 levels were associated with prevalent diabetes, prevalent obesity, and incident type 2 diabetes.<xref rid="jah38300-bib-0064" ref-type="bibr"><sup>64</sup></xref>, <xref rid="jah38300-bib-0065" ref-type="bibr"><sup>65</sup></xref>, <xref rid="jah38300-bib-0066" ref-type="bibr"><sup>66</sup></xref> In a case–control study of Spanish adults with and without type 2 diabetes (N=514), serum CD163 level was inversely associated with coffee and tea consumption.<xref rid="jah38300-bib-0066" ref-type="bibr"><sup>66</sup></xref> In Taiwanese adults (n=166, 84% with nonalcoholic fatty liver disease), greater intake of refined carbohydrates (noodles, desserts) and low intake of vegetables, dairy, seafood, and soy was positively associated with serum CD163.<xref rid="jah38300-bib-0067" ref-type="bibr"><sup>67</sup></xref> Differences in study results may be attributable to differences in diet exposures, study populations, and possible residual confounding in prior studies. To our knowledge, this is the first study that reported the effect of randomized diets on blood CD163. Future studies on the mechanism through which the DASH diet is associated with circulating CD163 is warranted.</p>
              <p>The primary strengths of our study are related to the study design. We used stored specimens from rigorously conducted feeding studies. In the DASH and DASH‐Sodium trials, participants received all of their meals, ate 1 meal onsite on weekdays, and adherence to the interventions was high as documented with urinary excretion of potassium, phosphorus, and urea nitrogen.<xref rid="jah38300-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="jah38300-bib-0003" ref-type="bibr"><sup>3</sup></xref> Participants were randomly assigned to diet interventions, which would have distributed measured and unmeasured confounders equally across the diet interventions. In addition, participants' weight was maintained stable, minimizing confounding because of weight loss. Therefore, serum proteins that were significantly different between the DASH diet and the control diet likely reflect the true biologic effect of diet, making these trials an ideal setting for discovery of the protein biomarkers of the DASH diet. Furthermore, validation of the proteomic biomarkers of the DASH diet score in a large independent study population of Black and White adults (the ARIC study) demonstrates the robustness of the findings. In the ARIC study, the magnitude of the difference based on C statistics was modest, which may be attributable to the use of DASH diet score versus dietary interventions in the feeding trials (DASH and DASH‐Sodium). Nonetheless, it is encouraging that the protein biomarkers discovered in randomized feeding studies validated in a free‐living population, who were not recommended to follow the DASH diet. Our results suggest the broader use of these biomarkers in the general population. Although the cost of untargeted proteomic profiling remains a barrier, in the future, targeted assays of a selected panel of proteins may be used to assess the degree of adherence to the DASH diet.</p>
              <p>The study also has limitations. The DASH and DASH‐Sodium trials used a limited set of menus (7‐day cycle, repeated each week), which could have led to fewer identified proteins had the study been conducted in free‐living people eating a much greater variety of foods. The DASH trial, DASH‐Sodium trials, and the ARIC study were conducted in the 1990s, which may not reflect the current food supply. It would be important to validate these proteins in modern studies. Although all biospecimens were frozen and never thawed, biospecimens were in storage for &gt;20 years. Degradation of proteins is possible, although it would be similar by diet interventions in the feeding studies and adherence to the DASH diet in the observational study. The number of proteins available in the ARIC study was smaller (≈5000 proteins) than the DASH and DASH‐Sodium trials (&gt;7000 proteins). As a result, of the 71 proteins that were significantly different between the DASH diet and control diet interventions, 50 proteins were available in the ARIC study. We may have found a greater number of validated proteins if the number of available proteins was comparable across the studies. Furthermore, this proteomics assay provides only relative abundance, and there are no data on absolute concentration of the validated proteins. We used archived serum specimens from the DASH and DASH‐Sodium trials, and plasma specimens from the ARIC study. However, there is no evidence that differences in sample matrices would confound the findings.</p>
              <p>In conclusion, our study addresses important gaps in nutritional epidemiologic research by providing candidate objective biomarkers of dietary intake to replace or complement self‐reported dietary intake. We identified 19 proteins robustly associated with the DASH diet in the DASH trial, DASH‐Sodium trial, and ARIC study, which may serve as biomarkers of the DASH diet. Our proteomics approach provides complementary information to serum and urine metabolomic markers of the DASH diet that were previously reported in feeding trials and observational studies.<xref rid="jah38300-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="jah38300-bib-0068" ref-type="bibr"><sup>68</sup></xref>, <xref rid="jah38300-bib-0069" ref-type="bibr"><sup>69</sup></xref>, <xref rid="jah38300-bib-0070" ref-type="bibr"><sup>70</sup></xref>, <xref rid="jah38300-bib-0071" ref-type="bibr"><sup>71</sup></xref>, <xref rid="jah38300-bib-0072" ref-type="bibr"><sup>72</sup></xref> Our findings not only directly reflect dietary intake and represent dietary biomarkers, but also highlight potential mechanisms (eg, lowering inflammation and collagen deposition) that underlie the associations between the DASH diet and cardiometabolic disease.</p>
            </sec>
            <sec id="jah38300-sec-0023">
              <title>Sources of Funding</title>
              <p>This research was supported by the National Heart, Lung, and Blood Institute (R01 HL153178). The ARIC study was supported by the National Heart, Lung, and Blood Institute, National Institutes of Health, and U. S. Department of Health and Human Services (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, and HHSN268201700005I). C.M.R. was additionally supported by a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (R03 DK128386). O.T. was supported by a grant from the National Heart, Lung, and Blood Institute (T32HL007024).</p>
            </sec>
            <sec id="jah38300-sec-0024">
              <title>Disclosures</title>
              <p>None.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="jah38300-supitem-0001" position="float" content-type="local-data">
                <caption>
                  <p>Data S1</p>
                  <p>Tables S1–S3</p>
                  <p>Figures S1–S2</p>
                </caption>
                <media xlink:href="JAH3-12-e028821-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jah38300-sec-0022">
              <title>Acknowledgments</title>
              <p>The authors thank the staff and participants of the ARIC study for their important contributions. In the ARIC study, proteomic assays were conducted free of charge as part of a data exchange agreement with SomaLogic. H.K. wrote the article and analyzed the data. H.K. had the primary responsibility for the final content. A.H.L., P.G., S.D., O.T., B.Y., N.C., L.J.A., and J.C. contributed to article revision and gave critical suggestions for the development of this article. C.M.R. was involved in all aspects of the study, from study design to analysis to article writing. All authors approved the article.</p>
            </ack>
            <ref-list content-type="cited-references" id="jah38300-bibl-0001">
              <title>REFERENCES</title>
              <ref id="jah38300-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="book" id="jah38300-cit-0001"><collab collab-type="authors">US Department of Agriculture</collab>
. <source>US Department of Health and Human Services, Health and Human Services. Dietary Guidelines for Americans, 2020–2025</source>. <publisher-name>US Government Printing Office</publisher-name>; <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="jah38300-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0002"><string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Moore</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Vogt</surname><given-names>TM</given-names></string-name>, <string-name><surname>Cutler</surname><given-names>JA</given-names></string-name>, <string-name><surname>Windhauser</surname><given-names>MM</given-names></string-name>, et al. <article-title>A clinical trial of the effects of dietary patterns on blood pressure</article-title>. <source>N Engl J Med.</source><year>1997</year>;<volume>336</volume>:<fpage>1117</fpage>–<lpage>1124</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJM199704173361601</pub-id>
<pub-id pub-id-type="pmid">9099655</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0003"><string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Harsha</surname><given-names>D</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Conlin</surname><given-names>PR</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names></string-name>, <string-name><surname>Simons‐Morton</surname><given-names>DG</given-names></string-name>, et al. <article-title>Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet</article-title>. <source>N Engl J Med.</source><year>2001</year>;<volume>344</volume>:<fpage>3</fpage>–<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJM200101043440101</pub-id>
<pub-id pub-id-type="pmid">11136953</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0004"><string-name><surname>Fung</surname><given-names>TT</given-names></string-name>, <string-name><surname>Chiuve</surname><given-names>SE</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>ML</given-names></string-name>, <string-name><surname>Rexrode</surname><given-names>KM</given-names></string-name>, <string-name><surname>Logroscino</surname><given-names>G</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name>. <article-title>Adherence to a DASH‐style diet and risk of coronary heart disease and stroke in women</article-title>. <source>Arch Intern Med.</source><year>2008</year>;<volume>168</volume>:<fpage>713</fpage>–<lpage>720</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinte.168.7.713</pub-id>
<pub-id pub-id-type="pmid">18413553</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0005"><string-name><surname>Schwingshackl</surname><given-names>L</given-names></string-name>, <string-name><surname>Bogensberger</surname><given-names>B</given-names></string-name>, <string-name><surname>Hoffmann</surname><given-names>G</given-names></string-name>. <article-title>Diet quality as assessed by the Healthy Eating Index, the Alternative Healthy Eating Index, Dietary Approaches to Stop Hypertension score, and health outcomes: an updated systematic review and meta‐analysis of cohort studies</article-title>. <source>J Acad Nutr Diet.</source><year>2018</year>;<volume>118</volume>:<fpage>74</fpage>–<lpage>100.e11</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jand.2017.08.024</pub-id>
<pub-id pub-id-type="pmid">29111090</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0006"><string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>, <string-name><surname>Crews</surname><given-names>DC</given-names></string-name>, <string-name><surname>Grams</surname><given-names>ME</given-names></string-name>, <string-name><surname>Steffen</surname><given-names>LM</given-names></string-name>, <string-name><surname>Levey</surname><given-names>AS</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names><suffix>III</suffix></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>. <article-title>DASH (Dietary Approaches to Stop Hypertension) diet and risk of subsequent kidney disease</article-title>. <source>Am J Kidney Dis.</source><year>2016</year>;<volume>68</volume>:<fpage>853</fpage>–<lpage>861</lpage>. doi: <pub-id pub-id-type="doi">10.1053/j.ajkd.2016.05.019</pub-id>
<pub-id pub-id-type="pmid">27519166</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0007"><string-name><surname>Forman</surname><given-names>JP</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Curhan</surname><given-names>GC</given-names></string-name>. <article-title>Diet and lifestyle risk factors associated with incident hypertension in women</article-title>. <source>JAMA.</source><year>2009</year>;<volume>302</volume>:<fpage>401</fpage>–<lpage>411</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2009.1060</pub-id>
<pub-id pub-id-type="pmid">19622819</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0008"><string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>, <string-name><surname>Lichtenstein</surname><given-names>AH</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Z</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>. <article-title>Serum untargeted metabolomic profile of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern</article-title>. <source>Am J Clin Nutr.</source><year>2018</year>;<volume>108</volume>:<fpage>243</fpage>–<lpage>255</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/nqy099</pub-id>
<pub-id pub-id-type="pmid">29917038</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0009"><string-name><surname>Freedman</surname><given-names>LS</given-names></string-name>, <string-name><surname>Schatzkin</surname><given-names>A</given-names></string-name>, <string-name><surname>Midthune</surname><given-names>D</given-names></string-name>, <string-name><surname>Kipnis</surname><given-names>V</given-names></string-name>. <article-title>Dealing with dietary measurement error in nutritional cohort studies</article-title>. <source>J Natl Cancer Inst.</source><year>2011</year>;<volume>103</volume>:<fpage>1086</fpage>–<lpage>1092</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jnci/djr189</pub-id>
<pub-id pub-id-type="pmid">21653922</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0010"><string-name><surname>Guasch‐Ferré</surname><given-names>M</given-names></string-name>, <string-name><surname>Bhupathiraju</surname><given-names>SN</given-names></string-name>, <string-name><surname>Hu</surname><given-names>FB</given-names></string-name>. <article-title>Use of metabolomics in improving assessment of dietary intake</article-title>. <source>Clin Chem.</source><year>2018</year>;<volume>64</volume>:<fpage>82</fpage>–<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1373/clinchem.2017.272344</pub-id>
<pub-id pub-id-type="pmid">29038146</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0011"><string-name><surname>Ramachandran</surname><given-names>VS</given-names></string-name>. <article-title>Biomarkers of cardiovascular disease</article-title>. <source>Circulation.</source><year>2006</year>;<volume>113</volume>:<fpage>2335</fpage>–<lpage>2362</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.482570</pub-id>
<pub-id pub-id-type="pmid">16702488</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0012"><string-name><surname>Schweigert</surname><given-names>FJ</given-names></string-name>. <article-title>Nutritional proteomics: methods and concepts for research in nutritional science</article-title>. <source>Ann Nutr Metab.</source><year>2007</year>;<volume>51</volume>:<fpage>99</fpage>–<lpage>107</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000102101</pub-id>
<pub-id pub-id-type="pmid">17476098</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0013"><string-name><surname>Lee</surname><given-names>SE</given-names></string-name>, <string-name><surname>Schulze</surname><given-names>K</given-names></string-name>, <string-name><surname>West</surname><given-names>KP</given-names></string-name>. <article-title>Rainer Gross Award lecture 2018: the childhood plasma proteome: discovering its applications in public health nutrition</article-title>. <source>Food Nutr Bull.</source><year>2019</year>;<volume>40</volume>:<fpage>144</fpage>–<lpage>150</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0379572119847851</pub-id>
<pub-id pub-id-type="pmid">31106587</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0014"><string-name><surname>Warensjö Lemming</surname><given-names>E</given-names></string-name>, <string-name><surname>Byberg</surname><given-names>L</given-names></string-name>, <string-name><surname>Stattin</surname><given-names>K</given-names></string-name>, <string-name><surname>Ahmad</surname><given-names>S</given-names></string-name>, <string-name><surname>Lind</surname><given-names>L</given-names></string-name>, <string-name><surname>Elmståhl</surname><given-names>S</given-names></string-name>, <string-name><surname>Larsson</surname><given-names>SC</given-names></string-name>, <string-name><surname>Wolk</surname><given-names>A</given-names></string-name>, <string-name><surname>Michaëlsson</surname><given-names>K</given-names></string-name>. <article-title>Dietary pattern specific protein biomarkers for cardiovascular disease: a cross‐sectional study in 2 independent cohorts</article-title>. <source>J Am Heart Assoc.</source><year>2019</year>;<volume>8</volume>:<elocation-id>e011860</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.118.011860</pub-id><pub-id pub-id-type="pmid">31433701</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0015"><string-name><surname>Walker</surname><given-names>ME</given-names></string-name>, <string-name><surname>Song</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Xu</surname><given-names>X</given-names></string-name>, <string-name><surname>Gerszten</surname><given-names>RE</given-names></string-name>, <string-name><surname>Ngo</surname><given-names>D</given-names></string-name>, <string-name><surname>Clish</surname><given-names>CB</given-names></string-name>, <string-name><surname>Corlin</surname><given-names>L</given-names></string-name>, <string-name><surname>Ma</surname><given-names>J</given-names></string-name>, <string-name><surname>Xanthakis</surname><given-names>V</given-names></string-name>, <string-name><surname>Jacques</surname><given-names>PF</given-names></string-name>, et al. <article-title>Proteomic and metabolomic correlates of healthy dietary patterns: the Framingham Heart Study</article-title>. <source>Nutrients.</source><year>2020</year>;<volume>12</volume>:<fpage>1476</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu12051476</pub-id><pub-id pub-id-type="pmid">32438708</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0016"><string-name><surname>Brennan</surname><given-names>L</given-names></string-name>. <article-title>The nutritional metabolomics crossroads: how to ensure success for dietary biomarkers</article-title>. <source>Am J Clin Nutr.</source><year>2017</year>;<volume>105</volume>:<fpage>293</fpage>–<lpage>294</lpage>. doi: <pub-id pub-id-type="doi">10.3945/ajcn.116.150847</pub-id>
<pub-id pub-id-type="pmid">28100510</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0017"><string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Windhauser</surname><given-names>MM</given-names></string-name>, <string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>McCullough</surname><given-names>M</given-names></string-name>, <string-name><surname>Karanja</surname><given-names>N</given-names></string-name>, <string-name><surname>Lin</surname><given-names>PH</given-names></string-name>, <string-name><surname>Steele</surname><given-names>P</given-names></string-name>, <string-name><surname>Proschan</surname><given-names>MA</given-names></string-name>. <article-title>Rationale and design of the Dietary Approaches to Stop Hypertension trial (DASH). A multicenter controlled‐feeding study of dietary patterns to lower blood pressure</article-title>. <source>Ann Epidemiol.</source><year>1995</year>;<volume>5</volume>:<fpage>108</fpage>–<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.1016/1047-2797(94)00055-X</pub-id>
<pub-id pub-id-type="pmid">7795829</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0018"><string-name><surname>Svetkey</surname><given-names>LP</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Lin</surname><given-names>PH</given-names></string-name>, <string-name><surname>Karanja</surname><given-names>NM</given-names></string-name>, <string-name><surname>Harsha</surname><given-names>DW</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Aickin</surname><given-names>M</given-names></string-name>, et al. <article-title>The DASH diet, Sodium Intake and Blood Pressure Trial (DASH‐sodium): rationale and design. DASH‐sodium Collaborative Research Group</article-title>. <source>J Am Diet Assoc.</source><year>1999</year>;<volume>99</volume>:<fpage>S96</fpage>–<lpage>S104</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0002-8223(99)00423-X</pub-id>
<pub-id pub-id-type="pmid">10450301</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0019"><string-name><surname>Giffen</surname><given-names>CA</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>LE</given-names></string-name>, <string-name><surname>Adams</surname><given-names>JT</given-names></string-name>, <string-name><surname>Brennan</surname><given-names>SP</given-names></string-name>, <string-name><surname>Coady</surname><given-names>SA</given-names></string-name>, <string-name><surname>Wagner</surname><given-names>EL</given-names></string-name>. <article-title>Providing contemporary access to historical biospecimen collections: development of the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC)</article-title>. <source>Biopreserv Biobank.</source><year>2015</year>;<volume>13</volume>:<fpage>271</fpage>–<lpage>279</lpage>. doi: <pub-id pub-id-type="doi">10.1089/bio.2014.0050</pub-id>
<pub-id pub-id-type="pmid">26186276</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0020"><string-name><surname>Gold</surname><given-names>L</given-names></string-name>, <string-name><surname>Ayers</surname><given-names>D</given-names></string-name>, <string-name><surname>Bertino</surname><given-names>J</given-names></string-name>, <string-name><surname>Bock</surname><given-names>C</given-names></string-name>, <string-name><surname>Bock</surname><given-names>A</given-names></string-name>, <string-name><surname>Brody</surname><given-names>EN</given-names></string-name>, <string-name><surname>Carter</surname><given-names>J</given-names></string-name>, <string-name><surname>Dalby</surname><given-names>AB</given-names></string-name>, <string-name><surname>Eaton</surname><given-names>BE</given-names></string-name>, <string-name><surname>Fitzwater</surname><given-names>T</given-names></string-name>, et al. <article-title>Aptamer‐based multiplexed proteomic technology for biomarker discovery</article-title>. <source>PLoS One.</source><year>2010</year>;<volume>5</volume>:<elocation-id>e15004</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0015004</pub-id><pub-id pub-id-type="pmid">21165148</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0021"><string-name><surname>Candia</surname><given-names>J</given-names></string-name>, <string-name><surname>Cheung</surname><given-names>F</given-names></string-name>, <string-name><surname>Kotliarov</surname><given-names>Y</given-names></string-name>, <string-name><surname>Fantoni</surname><given-names>G</given-names></string-name>, <string-name><surname>Sellers</surname><given-names>B</given-names></string-name>, <string-name><surname>Griesman</surname><given-names>T</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J</given-names></string-name>, <string-name><surname>Stuccio</surname><given-names>S</given-names></string-name>, <string-name><surname>Zingone</surname><given-names>A</given-names></string-name>, <string-name><surname>Ryan</surname><given-names>BM</given-names></string-name>, et al. <article-title>Assessment of variability in the SOMAscan assay</article-title>. <source>Sci Rep.</source><year>2017</year>;<volume>7</volume>:<fpage>14248</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-017-14755-5</pub-id><pub-id pub-id-type="pmid">29079756</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0022"><string-name><surname>Williams</surname><given-names>SA</given-names></string-name>, <string-name><surname>Kivimaki</surname><given-names>M</given-names></string-name>, <string-name><surname>Langenberg</surname><given-names>C</given-names></string-name>, <string-name><surname>Hingorani</surname><given-names>AD</given-names></string-name>, <string-name><surname>Casas</surname><given-names>JP</given-names></string-name>, <string-name><surname>Bouchard</surname><given-names>C</given-names></string-name>, <string-name><surname>Jonasson</surname><given-names>C</given-names></string-name>, <string-name><surname>Sarzynski</surname><given-names>MA</given-names></string-name>, <string-name><surname>Shipley</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Alexander</surname><given-names>L</given-names></string-name>, et al. <article-title>Plasma protein patterns as comprehensive indicators of health</article-title>. <source>Nat Med.</source><year>2019</year>;<volume>25</volume>:<fpage>1851</fpage>–<lpage>1857</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41591-019-0665-2</pub-id>
<pub-id pub-id-type="pmid">31792462</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0023"><string-name><surname>Ganz</surname><given-names>P</given-names></string-name>, <string-name><surname>Heidecker</surname><given-names>B</given-names></string-name>, <string-name><surname>Hveem</surname><given-names>K</given-names></string-name>, <string-name><surname>Jonasson</surname><given-names>C</given-names></string-name>, <string-name><surname>Kato</surname><given-names>S</given-names></string-name>, <string-name><surname>Segal</surname><given-names>MR</given-names></string-name>, <string-name><surname>Sterling</surname><given-names>DG</given-names></string-name>, <string-name><surname>Williams</surname><given-names>SA</given-names></string-name>. <article-title>Development and validation of a protein‐based risk score for cardiovascular outcomes among patients with stable coronary heart disease</article-title>. <source>JAMA.</source><year>2016</year>;<volume>315</volume>:<fpage>2532</fpage>–<lpage>2541</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2016.5951</pub-id>
<pub-id pub-id-type="pmid">27327800</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0024"><string-name><surname>Tin</surname><given-names>A</given-names></string-name>, <string-name><surname>Yu</surname><given-names>B</given-names></string-name>, <string-name><surname>Ma</surname><given-names>J</given-names></string-name>, <string-name><surname>Masushita</surname><given-names>K</given-names></string-name>, <string-name><surname>Daya</surname><given-names>N</given-names></string-name>, <string-name><surname>Hoogeveen</surname><given-names>RC</given-names></string-name>, <string-name><surname>Ballantyne</surname><given-names>CM</given-names></string-name>, <string-name><surname>Couper</surname><given-names>D</given-names></string-name>, <string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>, <string-name><surname>Grams</surname><given-names>ME</given-names></string-name>, et al. <article-title>Reproducibility and variability of protein analytes measured using a multiplexed modified aptamer assay</article-title>. <source>J Appl Lab Med.</source><year>2019</year>;<volume>4</volume>:<fpage>30</fpage>–<lpage>39</lpage>. doi: <pub-id pub-id-type="doi">10.1373/jalm.2018.027086</pub-id>
<pub-id pub-id-type="pmid">31639705</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0025"><string-name><surname>Wright</surname><given-names>JD</given-names></string-name>, <string-name><surname>Folsom</surname><given-names>AR</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>, <string-name><surname>Sharrett</surname><given-names>AR</given-names></string-name>, <string-name><surname>Couper</surname><given-names>D</given-names></string-name>, <string-name><surname>Wagenknecht</surname><given-names>LE</given-names></string-name>, <string-name><surname>Mosley</surname><given-names>TH</given-names></string-name>, <string-name><surname>Ballantyne</surname><given-names>CM</given-names></string-name>, <string-name><surname>Boerwinkle</surname><given-names>EA</given-names></string-name>, <string-name><surname>Rosamond</surname><given-names>WD</given-names></string-name>, et al. <article-title>The ARIC (Atherosclerosis Risk In Communities) study: JACC focus seminar 3/8</article-title>. <source>J Am Coll Cardiol.</source><year>2021</year>;<volume>77</volume>:<fpage>2939</fpage>–<lpage>2959</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jacc.2021.04.035</pub-id>
<pub-id pub-id-type="pmid">34112321</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0026"><string-name><surname>Hu</surname><given-names>EA</given-names></string-name>, <string-name><surname>Steffen</surname><given-names>LM</given-names></string-name>, <string-name><surname>Grams</surname><given-names>ME</given-names></string-name>, <string-name><surname>Crews</surname><given-names>DC</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>. <article-title>Dietary patterns and risk of incident chronic kidney disease: the Atherosclerosis Risk in Communities study</article-title>. <source>Am J Clin Nutr.</source><year>2019</year>;<volume>110</volume>:<fpage>713</fpage>–<lpage>721</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/nqz146</pub-id>
<pub-id pub-id-type="pmid">31386145</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0027"><string-name><surname>Walker</surname><given-names>KA</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Fornage</surname><given-names>M</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name><surname>Grams</surname><given-names>ME</given-names></string-name>, <string-name><surname>Tin</surname><given-names>A</given-names></string-name>, <string-name><surname>Daya</surname><given-names>N</given-names></string-name>, <string-name><surname>Hoogeveen</surname><given-names>RC</given-names></string-name>, et al. <article-title>Large‐scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk</article-title>. <source>Nat Aging.</source><year>2021</year>;<volume>1</volume>:<fpage>473</fpage>–<lpage>489</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s43587-021-00064-0</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38300-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0028"><string-name><surname>Grams</surname><given-names>ME</given-names></string-name>, <string-name><surname>Surapaneni</surname><given-names>A</given-names></string-name>, <string-name><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name><surname>Yu</surname><given-names>Z</given-names></string-name>, <string-name><surname>Dutta</surname><given-names>D</given-names></string-name>, <string-name><surname>Welling</surname><given-names>PA</given-names></string-name>, <string-name><surname>Chatterjee</surname><given-names>N</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Arking</surname><given-names>DE</given-names></string-name>, et al. <article-title>Proteins associated with risk of kidney function decline in the general population</article-title>. <source>J Am Soc Nephrol.</source><year>2021</year>;<volume>32</volume>:<fpage>2291</fpage>–<lpage>2302</lpage>. doi: <pub-id pub-id-type="doi">10.1681/ASN.2020111607</pub-id>
<pub-id pub-id-type="pmid">34465608</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0029"><string-name><surname>Benjamini</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yekutieli</surname><given-names>D</given-names></string-name>. <article-title>The control of the false discovery rate in multiple testing under dependency</article-title>. <source>Ann Stat.</source><year>2001</year>;<volume>29</volume>:<fpage>1165</fpage>–<lpage>1188</lpage>. doi: <pub-id pub-id-type="doi">10.1214/aos/1013699998</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38300-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0030"><string-name><surname>Cole</surname><given-names>RN</given-names></string-name>, <string-name><surname>Ruczinski</surname><given-names>I</given-names></string-name>, <string-name><surname>Schulze</surname><given-names>K</given-names></string-name>, <string-name><surname>Christian</surname><given-names>P</given-names></string-name>, <string-name><surname>Herbrich</surname><given-names>S</given-names></string-name>, <string-name><surname>Wu</surname><given-names>L</given-names></string-name>, <string-name><surname>Devine</surname><given-names>LR</given-names></string-name>, <string-name><surname>O'Meally</surname><given-names>RN</given-names></string-name>, <string-name><surname>Shrestha</surname><given-names>S</given-names></string-name>, <string-name><surname>Boronina</surname><given-names>TN</given-names></string-name>, et al. <article-title>The plasma proteome identifies expected and novel proteins correlated with micronutrient status in undernourished Nepalese children</article-title>. <source>J Nutr.</source><year>2013</year>;<volume>143</volume>:<fpage>1540</fpage>–<lpage>1548</lpage>. doi: <pub-id pub-id-type="doi">10.3945/jn.113.175018</pub-id>
<pub-id pub-id-type="pmid">23966331</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0031"><string-name><surname>Wibowo</surname><given-names>AS</given-names></string-name>, <string-name><surname>Singh</surname><given-names>M</given-names></string-name>, <string-name><surname>Reeder</surname><given-names>KM</given-names></string-name>, <string-name><surname>Carter</surname><given-names>JJ</given-names></string-name>, <string-name><surname>Kovach</surname><given-names>AR</given-names></string-name>, <string-name><surname>Meng</surname><given-names>W</given-names></string-name>, <string-name><surname>Ratnam</surname><given-names>M</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F</given-names></string-name>, <string-name><surname>Dann</surname><given-names>CE</given-names></string-name>. <article-title>Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition</article-title>. <source>Proc Natl Acad Sci USA.</source><year>2013</year>;<volume>110</volume>:<fpage>15180</fpage>–<lpage>15188</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1308827110</pub-id>
<pub-id pub-id-type="pmid">23934049</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0032"><string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names></string-name>, <string-name><surname>Jee</surname><given-names>SH</given-names></string-name>, <string-name><surname>Stolzenberg‐Solomon</surname><given-names>R</given-names></string-name>, <string-name><surname>Lin</surname><given-names>PH</given-names></string-name>, <string-name><surname>Erlinger</surname><given-names>T</given-names></string-name>, <string-name><surname>Nadeau</surname><given-names>MR</given-names></string-name>, <string-name><surname>Selhub</surname><given-names>J</given-names></string-name>. <article-title>Effect of dietary patterns on serum homocysteine: results of a randomized, controlled feeding study</article-title>. <source>Circulation.</source><year>2000</year>;<volume>102</volume>:<fpage>852</fpage>–<lpage>857</lpage>. doi: <pub-id pub-id-type="doi">10.1161/01.CIR.102.8.852</pub-id>
<pub-id pub-id-type="pmid">10952952</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0033"><string-name><surname>Dieplinger</surname><given-names>H</given-names></string-name>, <string-name><surname>Dieplinger</surname><given-names>B</given-names></string-name>. <article-title>Afamin—a pleiotropic glycoprotein involved in various disease states</article-title>. <source>Clin Chim Acta.</source><year>2015</year>;<volume>446</volume>:<fpage>105</fpage>–<lpage>110</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cca.2015.04.010</pub-id>
<pub-id pub-id-type="pmid">25892677</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0034"><string-name><surname>Jerkovic</surname><given-names>L</given-names></string-name>, <string-name><surname>Voegele</surname><given-names>AF</given-names></string-name>, <string-name><surname>Chwatal</surname><given-names>S</given-names></string-name>, <string-name><surname>Kronenberg</surname><given-names>F</given-names></string-name>, <string-name><surname>Radcliffe</surname><given-names>CM</given-names></string-name>, <string-name><surname>Wormald</surname><given-names>MR</given-names></string-name>, <string-name><surname>Lobentanz</surname><given-names>EM</given-names></string-name>, <string-name><surname>Ezeh</surname><given-names>B</given-names></string-name>, <string-name><surname>Eller</surname><given-names>P</given-names></string-name>, <string-name><surname>Dejori</surname><given-names>N</given-names></string-name>, et al. <article-title>Afamin is a novel human vitamin E‐binding glycoprotein characterization and in vitro expression</article-title>. <source>J Proteome Res.</source><year>2005</year>;<volume>4</volume>:<fpage>889</fpage>–<lpage>899</lpage>. doi: <pub-id pub-id-type="doi">10.1021/pr0500105</pub-id>
<pub-id pub-id-type="pmid">15952736</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0035"><string-name><surname>West</surname><given-names>KP</given-names></string-name>, <string-name><surname>Cole</surname><given-names>RN</given-names></string-name>, <string-name><surname>Shrestha</surname><given-names>S</given-names></string-name>, <string-name><surname>Schulze</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Lee</surname><given-names>SE</given-names></string-name>, <string-name><surname>Betz</surname><given-names>J</given-names></string-name>, <string-name><surname>Nonyane</surname><given-names>BA</given-names></string-name>, <string-name><surname>Wu</surname><given-names>LS‐F</given-names></string-name>, <string-name><surname>Yager</surname><given-names>JD</given-names></string-name>, <string-name><surname>Groopman</surname><given-names>JD</given-names></string-name>, et al. <article-title>A plasma α‐tocopherome can be identified from proteins associated with vitamin E status in school‐aged children of Nepal</article-title>. <source>J Nutr.</source><year>2015</year>;<volume>145</volume>:<fpage>2646</fpage>–<lpage>2656</lpage>. doi: <pub-id pub-id-type="doi">10.3945/jn.115.210682</pub-id>
<pub-id pub-id-type="pmid">26446483</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0036"><string-name><surname>Kurdiova</surname><given-names>T</given-names></string-name>, <string-name><surname>Balaz</surname><given-names>M</given-names></string-name>, <string-name><surname>Kovanicova</surname><given-names>Z</given-names></string-name>, <string-name><surname>Zemkova</surname><given-names>E</given-names></string-name>, <string-name><surname>Kuzma</surname><given-names>M</given-names></string-name>, <string-name><surname>Belan</surname><given-names>V</given-names></string-name>, <string-name><surname>Payer</surname><given-names>J</given-names></string-name>, <string-name><surname>Gasperikova</surname><given-names>D</given-names></string-name>, <string-name><surname>Dieplinger</surname><given-names>H</given-names></string-name>, <string-name><surname>Ukropcova</surname><given-names>B</given-names></string-name>, et al. <article-title>Serum afamin a novel marker of increased hepatic lipid content</article-title>. <source>Front Endocrinol (Lausanne).</source><year>2021</year>;<volume>12</volume>:<elocation-id>670425</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fendo.2021.670425</pub-id><pub-id pub-id-type="pmid">34603196</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0037"><string-name><surname>Kollerits</surname><given-names>B</given-names></string-name>, <string-name><surname>Lamina</surname><given-names>C</given-names></string-name>, <string-name><surname>Huth</surname><given-names>C</given-names></string-name>, <string-name><surname>Marques‐Vidal</surname><given-names>P</given-names></string-name>, <string-name><surname>Kiechl</surname><given-names>S</given-names></string-name>, <string-name><surname>Seppälä</surname><given-names>I</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>J</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>SC</given-names></string-name>, <string-name><surname>Meisinger</surname><given-names>C</given-names></string-name>, <string-name><surname>Herder</surname><given-names>C</given-names></string-name>, et al. <article-title>Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes: a pooled analysis in more than 20,000 individuals</article-title>. <source>Diabetes Care.</source><year>2017</year>;<volume>40</volume>:<fpage>1386</fpage>–<lpage>1393</lpage>. doi: <pub-id pub-id-type="doi">10.2337/dc17-0201</pub-id>
<pub-id pub-id-type="pmid">28877915</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0038"><string-name><surname>Kronenberg</surname><given-names>F</given-names></string-name>, <string-name><surname>Kollerits</surname><given-names>B</given-names></string-name>, <string-name><surname>Kiechl</surname><given-names>S</given-names></string-name>, <string-name><surname>Lamina</surname><given-names>C</given-names></string-name>, <string-name><surname>Kedenko</surname><given-names>L</given-names></string-name>, <string-name><surname>Meisinger</surname><given-names>C</given-names></string-name>, <string-name><surname>Willeit</surname><given-names>J</given-names></string-name>, <string-name><surname>Huth</surname><given-names>C</given-names></string-name>, <string-name><surname>Wietzorrek</surname><given-names>G</given-names></string-name>, <string-name><surname>Altmann</surname><given-names>ME</given-names></string-name>, et al. <article-title>Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome</article-title>. <source>Circ Cardiovasc Genet.</source><year>2014</year>;<volume>7</volume>:<fpage>822</fpage>–<lpage>829</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000654</pub-id>
<pub-id pub-id-type="pmid">25176938</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0039"><string-name><surname>Obarzanek</surname><given-names>E</given-names></string-name>, <string-name><surname>Sacks</surname><given-names>FM</given-names></string-name>, <string-name><surname>Vollmer</surname><given-names>WM</given-names></string-name>, <string-name><surname>Bray</surname><given-names>GA</given-names></string-name>, <string-name><surname>Miller</surname><given-names>ER</given-names></string-name>, <string-name><surname>Lin</surname><given-names>PH</given-names></string-name>, <string-name><surname>Karanja</surname><given-names>NM</given-names></string-name>, <string-name><surname>Most‐Windhauser</surname><given-names>MM</given-names></string-name>, <string-name><surname>Moore</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Swain</surname><given-names>JF</given-names></string-name>, et al. <article-title>Effects on blood lipids of a blood pressure‐lowering diet: the Dietary Approaches to Stop Hypertension (DASH) trial</article-title>. <source>Am J Clin Nutr.</source><year>2001</year>;<volume>74</volume>:<fpage>80</fpage>–<lpage>89</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/74.1.80</pub-id>
<pub-id pub-id-type="pmid">11451721</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0040"><string-name><surname>Pimenta</surname><given-names>AM</given-names></string-name>, <string-name><surname>Toledo</surname><given-names>E</given-names></string-name>, <string-name><surname>Rodriguez‐Diez</surname><given-names>MC</given-names></string-name>, <string-name><surname>Gea</surname><given-names>A</given-names></string-name>, <string-name><surname>Lopez‐Iracheta</surname><given-names>R</given-names></string-name>, <string-name><surname>Shivappa</surname><given-names>N</given-names></string-name>, <string-name><surname>Hébert</surname><given-names>JR</given-names></string-name>, <string-name><surname>Martinez‐Gonzalez</surname><given-names>MA</given-names></string-name>. <article-title>Dietary indexes, food patterns and incidence of metabolic syndrome in a Mediterranean cohort: the SUN project</article-title>. <source>Clin Nutr.</source><year>2015</year>;<volume>34</volume>:<fpage>508</fpage>–<lpage>514</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clnu.2014.06.002</pub-id>
<pub-id pub-id-type="pmid">24975512</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0041"><string-name><surname>Liese</surname><given-names>AD</given-names></string-name>, <string-name><surname>Nichols</surname><given-names>M</given-names></string-name>, <string-name><surname>Sun</surname><given-names>X</given-names></string-name>, <string-name><surname>D'Agostino</surname><given-names>RB</given-names></string-name>, <string-name><surname>Haffner</surname><given-names>SM</given-names></string-name>. <article-title>Adherence to the DASH diet is inversely associated with incidence of type 2 diabetes: the Insulin Resistance Atherosclerosis Study</article-title>. <source>Diabetes Care.</source><year>2009</year>;<volume>32</volume>:<fpage>1434</fpage>–<lpage>1436</lpage>. doi: <pub-id pub-id-type="doi">10.2337/dc09-0228</pub-id>
<pub-id pub-id-type="pmid">19487638</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0042"><string-name><surname>Jannasch</surname><given-names>F</given-names></string-name>, <string-name><surname>Kröger</surname><given-names>J</given-names></string-name>, <string-name><surname>Schulze</surname><given-names>MB</given-names></string-name>. <article-title>Dietary patterns and type 2 diabetes: a systematic literature review and meta‐analysis of prospective studies</article-title>. <source>J Nutr.</source><year>2017</year>;<volume>147</volume>:<fpage>1174</fpage>–<lpage>1182</lpage>. doi: <pub-id pub-id-type="doi">10.3945/jn.116.242552</pub-id>
<pub-id pub-id-type="pmid">28424256</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0043"><string-name><surname>Rattik</surname><given-names>S</given-names></string-name>, <string-name><surname>Wigren</surname><given-names>M</given-names></string-name>, <string-name><surname>Björkbacka</surname><given-names>H</given-names></string-name>, <string-name><surname>Fredrikson</surname><given-names>GN</given-names></string-name>, <string-name><surname>Hedblad</surname><given-names>B</given-names></string-name>, <string-name><surname>Siegbahn</surname><given-names>A</given-names></string-name>, <string-name><surname>Bengtsson</surname><given-names>E</given-names></string-name>, <string-name><surname>Schiopu</surname><given-names>A</given-names></string-name>, <string-name><surname>Edsfeldt</surname><given-names>A</given-names></string-name>, <string-name><surname>Dunér</surname><given-names>P</given-names></string-name>, et al. <article-title>High plasma levels of heparin‐binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events</article-title>. <source>Arterioscler Thromb Vasc Biol.</source><year>2015</year>;<volume>35</volume>:<fpage>222</fpage>–<lpage>228</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.114.304369</pub-id>
<pub-id pub-id-type="pmid">25359857</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0044"><string-name><surname>Ko</surname><given-names>D</given-names></string-name>, <string-name><surname>Benson</surname><given-names>MD</given-names></string-name>, <string-name><surname>Ngo</surname><given-names>D</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Larson</surname><given-names>MG</given-names></string-name>, <string-name><surname>Wang</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Trinquart</surname><given-names>L</given-names></string-name>, <string-name><surname>McManus</surname><given-names>DD</given-names></string-name>, <string-name><surname>Lubitz</surname><given-names>SA</given-names></string-name>, <string-name><surname>Ellinor</surname><given-names>PT</given-names></string-name>, et al. <article-title>Proteomics profiling and risk of new‐onset atrial fibrillation: Framingham Heart Study</article-title>. <source>J Am Heart Assoc.</source><year>2019</year>;<volume>8</volume>:<elocation-id>e010976</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.118.010976</pub-id><pub-id pub-id-type="pmid">30841775</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0045"><string-name><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Xia</surname><given-names>M</given-names></string-name>, <string-name><surname>Jin</surname><given-names>K</given-names></string-name>, <string-name><surname>Wang</surname><given-names>S</given-names></string-name>, <string-name><surname>Wei</surname><given-names>H</given-names></string-name>, <string-name><surname>Fan</surname><given-names>C</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Li</surname><given-names>X</given-names></string-name>, <string-name><surname>Li</surname><given-names>G</given-names></string-name>, et al. <article-title>Function of the c‐met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities</article-title>. <source>Mol Cancer.</source><year>2018</year>;<volume>17</volume>:<fpage>45</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12943-018-0796-y</pub-id><pub-id pub-id-type="pmid">29455668</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0046"><string-name><surname>Bell</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Decker</surname><given-names>PA</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>MY</given-names></string-name>, <string-name><surname>Pankow</surname><given-names>JS</given-names></string-name>, <string-name><surname>Hanson</surname><given-names>NQ</given-names></string-name>, <string-name><surname>Wassel</surname><given-names>CL</given-names></string-name>, <string-name><surname>Larson</surname><given-names>NB</given-names></string-name>, <string-name><surname>Cohoon</surname><given-names>KP</given-names></string-name>, <string-name><surname>Budoff</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Polak</surname><given-names>JF</given-names></string-name>, et al. <article-title>Hepatocyte growth factor is associated with progression of atherosclerosis: the Multi‐Ethnic Study of Atherosclerosis (MESA)</article-title>. <source>Atherosclerosis.</source><year>2018</year>;<volume>272</volume>:<fpage>162</fpage>–<lpage>167</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2018.03.040</pub-id>
<pub-id pub-id-type="pmid">29609131</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0047"><string-name><surname>Bell</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Larson</surname><given-names>NB</given-names></string-name>, <string-name><surname>Decker</surname><given-names>PA</given-names></string-name>, <string-name><surname>Pankow</surname><given-names>JS</given-names></string-name>, <string-name><surname>Tsai</surname><given-names>MY</given-names></string-name>, <string-name><surname>Hanson</surname><given-names>NQ</given-names></string-name>, <string-name><surname>Wassel</surname><given-names>CL</given-names></string-name>, <string-name><surname>Longstreth</surname><given-names>W</given-names></string-name>, <string-name><surname>Bielinski</surname><given-names>SJ</given-names></string-name>. <article-title>Hepatocyte growth factor is positively associated with risk of stroke</article-title>. <source>Stroke.</source><year>2016</year>;<volume>47</volume>:<fpage>2689</fpage>–<lpage>2694</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.116.014172</pub-id>
<pub-id pub-id-type="pmid">27729582</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0048"><string-name><surname>Gallo</surname><given-names>S</given-names></string-name>, <string-name><surname>Sala</surname><given-names>V</given-names></string-name>, <string-name><surname>Gatti</surname><given-names>S</given-names></string-name>, <string-name><surname>Crepaldi</surname><given-names>T</given-names></string-name>. <article-title>Cellular and molecular mechanisms of HGF/Met in the cardiovascular system</article-title>. <source>Clin Sci (Lond).</source><year>2015</year>;<volume>129</volume>:<fpage>1173</fpage>–<lpage>1193</lpage>. doi: <pub-id pub-id-type="doi">10.1042/CS20150502</pub-id>
<pub-id pub-id-type="pmid">26561593</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0049"><string-name><surname>Arechederra</surname><given-names>M</given-names></string-name>, <string-name><surname>Carmona</surname><given-names>R</given-names></string-name>, <string-name><surname>González‐Nuñez</surname><given-names>M</given-names></string-name>, <string-name><surname>Gutiérrez‐Uzquiza</surname><given-names>A</given-names></string-name>, <string-name><surname>Bragado</surname><given-names>P</given-names></string-name>, <string-name><surname>Cruz‐González</surname><given-names>I</given-names></string-name>, <string-name><surname>Cano</surname><given-names>E</given-names></string-name>, <string-name><surname>Guerrero</surname><given-names>C</given-names></string-name>, <string-name><surname>Sánchez</surname><given-names>A</given-names></string-name>, <string-name><surname>López‐Novoa</surname><given-names>JM</given-names></string-name>, et al. <article-title>Met signaling in cardiomyocytes is required for normal cardiac function in adult mice</article-title>. <source>Biochim Biophys Acta.</source><year>2013</year>;<volume>1832</volume>:<fpage>2204</fpage>–<lpage>2215</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbadis.2013.08.008</pub-id>
<pub-id pub-id-type="pmid">23994610</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0050">
                <label>50</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0050"><string-name><surname>Tani</surname><given-names>M</given-names></string-name>, <string-name><surname>Igarashi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ito</surname><given-names>M</given-names></string-name>. <article-title>Involvement of neutral ceramidase in ceramide metabolism at the plasma membrane and in extracellular milieu</article-title>. <source>J Biol Chem.</source><year>2005</year>;<volume>280</volume>:<fpage>36592</fpage>–<lpage>36600</lpage>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M506827200</pub-id>
<pub-id pub-id-type="pmid">16126722</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0051">
                <label>51</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0051"><string-name><surname>Zhu</surname><given-names>Q</given-names></string-name>, <string-name><surname>Kang</surname><given-names>J</given-names></string-name>, <string-name><surname>Miao</surname><given-names>H</given-names></string-name>, <string-name><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>L</given-names></string-name>, <string-name><surname>Hu</surname><given-names>Z</given-names></string-name>, <string-name><surname>Liao</surname><given-names>D‐F</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Jin</surname><given-names>J</given-names></string-name>, <string-name><surname>He</surname><given-names>S</given-names></string-name>. <article-title>Low‐dose cytokine‐induced neutral ceramidase secretion from INS‐1 cells via exosomes and its anti‐apoptotic effect</article-title>. <source>FEBS J.</source><year>2014</year>;<volume>281</volume>:<fpage>2861</fpage>–<lpage>2870</lpage>. doi: <pub-id pub-id-type="doi">10.1111/febs.12826</pub-id>
<pub-id pub-id-type="pmid">24798654</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0052">
                <label>52</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0052"><string-name><surname>Ardigo</surname><given-names>D</given-names></string-name>, <string-name><surname>Assimes</surname><given-names>TL</given-names></string-name>, <string-name><surname>Fortmann</surname><given-names>SP</given-names></string-name>, <string-name><surname>Go</surname><given-names>AS</given-names></string-name>, <string-name><surname>Hlatky</surname><given-names>M</given-names></string-name>, <string-name><surname>Hytopoulos</surname><given-names>E</given-names></string-name>, <string-name><surname>Iribarren</surname><given-names>C</given-names></string-name>, <string-name><surname>Tsao</surname><given-names>PS</given-names></string-name>, <string-name><surname>Tabibiazar</surname><given-names>R</given-names></string-name>, <string-name><surname>Quertermous</surname><given-names>T</given-names></string-name>, et al. <article-title>Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease</article-title>. <source>Physiol Genomics.</source><year>2007</year>;<volume>31</volume>:<fpage>402</fpage>–<lpage>409</lpage>. doi: <pub-id pub-id-type="doi">10.1152/physiolgenomics.00104.2007</pub-id>
<pub-id pub-id-type="pmid">17698927</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0053">
                <label>53</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0053"><string-name><surname>Wu</surname><given-names>X</given-names></string-name>, <string-name><surname>Sun</surname><given-names>M</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Lu</surname><given-names>C</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q</given-names></string-name>, <string-name><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name><surname>Deng</surname><given-names>C</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y</given-names></string-name>. <article-title>The roles of CCR9/CCL25 in inflammation and inflammation‐associated diseases</article-title>. <source>Front Cell Dev Biol.</source><year>2021</year>;<volume>9</volume>:<elocation-id>686548</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fcell.2021.686548</pub-id><pub-id pub-id-type="pmid">34490243</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0054">
                <label>54</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0054"><string-name><surname>Dziarski</surname><given-names>R</given-names></string-name>, <string-name><surname>Gupta</surname><given-names>D</given-names></string-name>. <article-title>The peptidoglycan recognition proteins (PGRPs)</article-title>. <source>Genome Biol.</source><year>2006</year>;<volume>7</volume>:<fpage>232</fpage>. doi: <pub-id pub-id-type="doi">10.1186/gb-2006-7-8-232</pub-id><pub-id pub-id-type="pmid">16930467</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0055">
                <label>55</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0055"><string-name><surname>Lundsgaard</surname><given-names>A‐M</given-names></string-name>, <string-name><surname>Holm</surname><given-names>JB</given-names></string-name>, <string-name><surname>Sjøberg</surname><given-names>KA</given-names></string-name>, <string-name><surname>Bojsen‐Møller</surname><given-names>KN</given-names></string-name>, <string-name><surname>Myrmel</surname><given-names>LS</given-names></string-name>, <string-name><surname>Fjære</surname><given-names>E</given-names></string-name>, <string-name><surname>Jensen</surname><given-names>BAH</given-names></string-name>, <string-name><surname>Nicolaisen</surname><given-names>TS</given-names></string-name>, <string-name><surname>Hingst</surname><given-names>JR</given-names></string-name>, <string-name><surname>Hansen</surname><given-names>SL</given-names></string-name>, et al. <article-title>Mechanisms preserving insulin action during high dietary fat intake</article-title>. <source>Cell Metab.</source><year>2019</year>;<volume>29</volume>:<fpage>50</fpage>–<lpage>63.e4</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2018.08.022</pub-id>
<pub-id pub-id-type="pmid">30269983</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0056">
                <label>56</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0056"><string-name><surname>Bech</surname><given-names>A‐S</given-names></string-name>, <string-name><surname>Nexoe</surname><given-names>AB</given-names></string-name>, <string-name><surname>Dubik</surname><given-names>M</given-names></string-name>, <string-name><surname>Moeller</surname><given-names>JB</given-names></string-name>, <string-name><surname>Soerensen</surname><given-names>GL</given-names></string-name>, <string-name><surname>Holmskov</surname><given-names>U</given-names></string-name>, <string-name><surname>Madsen</surname><given-names>GI</given-names></string-name>, <string-name><surname>Husby</surname><given-names>S</given-names></string-name>, <string-name><surname>Rathe</surname><given-names>M</given-names></string-name>. <article-title>Peptidoglycan recognition peptide 2 aggravates weight loss in a murine model of chemotherapy‐induced gastrointestinal toxicity</article-title>. <source>Front Oncol.</source><year>2021</year>;<volume>11</volume>:<elocation-id>635005</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fonc.2021.635005</pub-id><pub-id pub-id-type="pmid">33833993</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0057">
                <label>57</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0057"><string-name><surname>Blumenthal</surname><given-names>JA</given-names></string-name>. <article-title>Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study</article-title>. <source>Arch Intern Med.</source><year>2010</year>;<volume>170</volume>:<fpage>126</fpage>–<lpage>135</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinternmed.2009.470</pub-id>
<pub-id pub-id-type="pmid">20101007</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0058">
                <label>58</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0058"><string-name><surname>Ruiz‐Villalba</surname><given-names>A</given-names></string-name>, <string-name><surname>Romero</surname><given-names>JP</given-names></string-name>, <string-name><surname>Hernández</surname><given-names>SC</given-names></string-name>, <string-name><surname>Vilas‐Zornoza</surname><given-names>A</given-names></string-name>, <string-name><surname>Fortelny</surname><given-names>N</given-names></string-name>, <string-name><surname>Castro‐Labrador</surname><given-names>L</given-names></string-name>, <string-name><surname>San Martin‐Uriz</surname><given-names>P</given-names></string-name>, <string-name><surname>Lorenzo‐Vivas</surname><given-names>E</given-names></string-name>, <string-name><surname>García‐Olloqui</surname><given-names>P</given-names></string-name>, <string-name><surname>Palacio</surname><given-names>M</given-names></string-name>, et al. <article-title>Single‐cell RNA sequencing analysis reveals a crucial role for CTHRC1 (collagen triple helix repeat containing 1) cardiac fibroblasts after myocardial infarction</article-title>. <source>Circulation.</source><year>2020</year>;<volume>142</volume>:<fpage>1831</fpage>–<lpage>1847</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.044557</pub-id>
<pub-id pub-id-type="pmid">32972203</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0059">
                <label>59</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0059"><string-name><surname>Nordquist</surname><given-names>EM</given-names></string-name>, <string-name><surname>Dutta</surname><given-names>P</given-names></string-name>, <string-name><surname>Kodigepalli</surname><given-names>KM</given-names></string-name>, <string-name><surname>Mattern</surname><given-names>C</given-names></string-name>, <string-name><surname>McDermott</surname><given-names>MR</given-names></string-name>, <string-name><surname>Trask</surname><given-names>AJ</given-names></string-name>, <string-name><surname>LaHaye</surname><given-names>S</given-names></string-name>, <string-name><surname>Lindner</surname><given-names>V</given-names></string-name>, <string-name><surname>Lincoln</surname><given-names>J</given-names></string-name>. <article-title>Tgfβ1‐Cthrc1 signaling plays an important role in the short‐term reparative response to heart valve endothelial injury</article-title>. <source>Arterioscler Thromb Vasc Biol.</source><year>2021</year>;<volume>41</volume>:<fpage>2923</fpage>–<lpage>2942</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.121.316450</pub-id>
<pub-id pub-id-type="pmid">34645278</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0060">
                <label>60</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0060"><string-name><surname>Lim</surname><given-names>HY</given-names></string-name>, <string-name><surname>Lim</surname><given-names>SY</given-names></string-name>, <string-name><surname>Tan</surname><given-names>CK</given-names></string-name>, <string-name><surname>Thiam</surname><given-names>CH</given-names></string-name>, <string-name><surname>Goh</surname><given-names>CC</given-names></string-name>, <string-name><surname>Carbajo</surname><given-names>D</given-names></string-name>, <string-name><surname>Chew</surname><given-names>SHS</given-names></string-name>, <string-name><surname>See</surname><given-names>P</given-names></string-name>, <string-name><surname>Chakarov</surname><given-names>S</given-names></string-name>, <string-name><surname>Wang</surname><given-names>XN</given-names></string-name>, et al. <article-title>Hyaluronan receptor LYVE‐1‐expressing macrophages maintain arterial tone through hyaluronan‐mediated regulation of smooth muscle cell collagen</article-title>. <source>Immunity.</source><year>2018</year>;<volume>49</volume>:<fpage>326</fpage>–<lpage>341.e7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2018.06.008</pub-id>
<pub-id pub-id-type="pmid">30054204</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0061">
                <label>61</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0061"><string-name><surname>Lagoutte</surname><given-names>P</given-names></string-name>, <string-name><surname>Bettler</surname><given-names>E</given-names></string-name>, <string-name><surname>Vadon‐Le Goff</surname><given-names>S</given-names></string-name>, <string-name><surname>Moali</surname><given-names>C</given-names></string-name>. <article-title>Procollagen C‐proteinase enhancer‐1 (PCPE‐1), a potential biomarker and therapeutic target for fibrosis</article-title>. <source>Matrix Biol Plus.</source><year>2021</year>;<volume>11</volume>:<elocation-id>100062</elocation-id>. doi: <pub-id pub-id-type="doi">10.1016/j.mbplus.2021.100062</pub-id><pub-id pub-id-type="pmid">34435180</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0062">
                <label>62</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0062"><string-name><surname>Sacre</surname><given-names>JW</given-names></string-name>, <string-name><surname>Jennings</surname><given-names>GLR</given-names></string-name>, <string-name><surname>Kingwell</surname><given-names>BA</given-names></string-name>. <article-title>Exercise and dietary influences on arterial stiffness in cardiometabolic disease</article-title>. <source>Hypertension.</source><year>2014</year>;<volume>63</volume>:<fpage>888</fpage>–<lpage>893</lpage>. doi: <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.113.02277</pub-id>
<pub-id pub-id-type="pmid">24516111</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0063">
                <label>63</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0063"><string-name><surname>Etzerodt</surname><given-names>A</given-names></string-name>, <string-name><surname>Moestrup</surname><given-names>SK</given-names></string-name>. <article-title>CD163 and inflammation: biological, diagnostic, and therapeutic aspects</article-title>. <source>Antioxid Redox Signal.</source><year>2013</year>;<volume>18</volume>:<fpage>2352</fpage>–<lpage>2363</lpage>. doi: <pub-id pub-id-type="doi">10.1089/ars.2012.4834</pub-id>
<pub-id pub-id-type="pmid">22900885</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0064">
                <label>64</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0064"><string-name><surname>Fjeldborg</surname><given-names>K</given-names></string-name>, <string-name><surname>Christiansen</surname><given-names>T</given-names></string-name>, <string-name><surname>Bennetzen</surname><given-names>M</given-names></string-name>, <string-name><surname>Møller H</surname><given-names>J</given-names></string-name>, <string-name><surname>Pedersen</surname><given-names>SB</given-names></string-name>, <string-name><surname>Richelsen</surname><given-names>B</given-names></string-name>. <article-title>The macrophage‐specific serum marker, soluble CD163, is increased in obesity and reduced after dietary‐induced weight loss</article-title>. <source>Obesity (Silver Spring)</source>. <year>2013</year>;<volume>21</volume>:<fpage>2437</fpage>–<lpage>2443</lpage>. doi: <pub-id pub-id-type="doi">10.1002/oby.20376</pub-id>
<pub-id pub-id-type="pmid">23512476</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0065">
                <label>65</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0065"><string-name><surname>Møller</surname><given-names>HJ</given-names></string-name>, <string-name><surname>Frikke‐Schmidt</surname><given-names>R</given-names></string-name>, <string-name><surname>Moestrup</surname><given-names>SK</given-names></string-name>, <string-name><surname>Nordestgaard</surname><given-names>BG</given-names></string-name>, <string-name><surname>Tybjærg‐Hansen</surname><given-names>A</given-names></string-name>. <article-title>Serum soluble CD163 predicts risk of type 2 diabetes in the general population</article-title>. <source>Clin Chem.</source><year>2011</year>;<volume>57</volume>:<fpage>291</fpage>–<lpage>297</lpage>. doi: <pub-id pub-id-type="doi">10.1373/clinchem.2010.154724</pub-id>
<pub-id pub-id-type="pmid">21106861</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0066">
                <label>66</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0066"><string-name><surname>Rojo‐Martínez</surname><given-names>G</given-names></string-name>, <string-name><surname>Maymó‐Masip</surname><given-names>E</given-names></string-name>, <string-name><surname>Rodríguez</surname><given-names>MM</given-names></string-name>, <string-name><surname>Solano</surname><given-names>E</given-names></string-name>, <string-name><surname>Goday</surname><given-names>A</given-names></string-name>, <string-name><surname>Soriguer</surname><given-names>F</given-names></string-name>, <string-name><surname>Valdés</surname><given-names>S</given-names></string-name>, <string-name><surname>Chaves</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Delgado</surname><given-names>E</given-names></string-name>, <string-name><surname>Colomo</surname><given-names>N</given-names></string-name>, et al. <article-title>Serum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study</article-title>. <source>PLoS One.</source><year>2014</year>;<volume>9</volume>:<elocation-id>e101250</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0101250</pub-id><pub-id pub-id-type="pmid">24978196</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0067">
                <label>67</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0067"><string-name><surname>Hu</surname><given-names>T‐Y</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S‐Y</given-names></string-name>, <string-name><surname>Shih</surname><given-names>C‐K</given-names></string-name>, <string-name><surname>Chou</surname><given-names>M‐J</given-names></string-name>, <string-name><surname>Wu</surname><given-names>M‐C</given-names></string-name>, <string-name><surname>Teng</surname><given-names>I‐C</given-names></string-name>, <string-name><surname>Bai</surname><given-names>C‐H</given-names></string-name>, <string-name><surname>Sabrina</surname><given-names>N</given-names></string-name>, <string-name><surname>Tinkov</surname><given-names>AA</given-names></string-name>, <string-name><surname>Skalny</surname><given-names>AV</given-names></string-name>, et al. <article-title>Soluble CD163‐associated dietary patterns and the risk of metabolic syndrome</article-title>. <source>Nutrients.</source><year>2019</year>;<volume>11</volume>:<fpage>940</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu11040940</pub-id><pub-id pub-id-type="pmid">31027316</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0068">
                <label>68</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0068"><string-name><surname>Kim</surname><given-names>H</given-names></string-name>, <string-name><surname>Lichtenstein</surname><given-names>AH</given-names></string-name>, <string-name><surname>Wong</surname><given-names>KE</given-names></string-name>, <string-name><surname>Appel</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>, <string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>. <article-title>Urine metabolites associated with the Dietary Approaches to Stop Hypertension (DASH) diet: results from the DASH‐sodium trial</article-title>. <source>Mol Nutr Food Res.</source><year>2020</year>;<volume>65</volume>:<elocation-id>e2000695</elocation-id>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.202000695</pub-id><pub-id pub-id-type="pmid">33300290</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0069">
                <label>69</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0069"><string-name><surname>Kim</surname><given-names>H</given-names></string-name>, <string-name><surname>Hu</surname><given-names>EA</given-names></string-name>, <string-name><surname>Wong</surname><given-names>K</given-names></string-name>, <string-name><surname>Yu</surname><given-names>B</given-names></string-name>, <string-name><surname>Steffen</surname><given-names>LM</given-names></string-name>, <string-name><surname>Seidelmann</surname><given-names>SB</given-names></string-name>, <string-name><surname>Boerwinkle</surname><given-names>E</given-names></string-name>, <string-name><surname>Coresh</surname><given-names>J</given-names></string-name>, <string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>. <article-title>Serum metabolites associated with healthy diets in African Americans and European Americans</article-title>. <source>J Nutr.</source><year>2021</year>;<volume>151</volume>:<fpage>40</fpage>–<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jn/nxaa338</pub-id>
<pub-id pub-id-type="pmid">33244610</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0070">
                <label>70</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0070"><string-name><surname>McCullough</surname><given-names>ML</given-names></string-name>, <string-name><surname>Maliniak</surname><given-names>ML</given-names></string-name>, <string-name><surname>Stevens</surname><given-names>VL</given-names></string-name>, <string-name><surname>Carter</surname><given-names>BD</given-names></string-name>, <string-name><surname>Hodge</surname><given-names>RA</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>. <article-title>Metabolomic markers of healthy dietary patterns in US postmenopausal women</article-title>. <source>Am J Clin Nutr.</source><year>2019</year>;<volume>109</volume>:<fpage>1439</fpage>–<lpage>1451</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ajcn/nqy385</pub-id>
<pub-id pub-id-type="pmid">31051511</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0071">
                <label>71</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0071"><string-name><surname>Rafiq</surname><given-names>T</given-names></string-name>, <string-name><surname>Azab</surname><given-names>SM</given-names></string-name>, <string-name><surname>Teo</surname><given-names>KK</given-names></string-name>, <string-name><surname>Thabane</surname><given-names>L</given-names></string-name>, <string-name><surname>Anand</surname><given-names>SS</given-names></string-name>, <string-name><surname>Morrison</surname><given-names>KM</given-names></string-name>, <string-name><surname>de Souza</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Britz‐McKibbin</surname><given-names>P</given-names></string-name>. <article-title>Nutritional metabolomics and the classification of dietary biomarker candidates: a critical review</article-title>. <source>Adv Nutr.</source><year>2021</year>;<volume>12</volume>:<fpage>2333</fpage>–<lpage>2357</lpage>. doi: <pub-id pub-id-type="doi">10.1093/advances/nmab054</pub-id>
<pub-id pub-id-type="pmid">34015815</pub-id></mixed-citation>
              </ref>
              <ref id="jah38300-bib-0072">
                <label>72</label>
                <mixed-citation publication-type="journal" id="jah38300-cit-0072"><string-name><surname>Kim</surname><given-names>H</given-names></string-name>, <string-name><surname>Rebholz</surname><given-names>CM</given-names></string-name>. <article-title>Metabolomic biomarkers of healthy dietary patterns and cardiovascular outcomes</article-title>. <source>Curr Atheroscler Rep.</source><year>2021</year>;<volume>23</volume>:<fpage>26</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s11883-021-00921-8</pub-id><pub-id pub-id-type="pmid">33782776</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
